FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Sverre Kjeldsen

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Procedures

Double-Blind Method

Anatomy

Sympathetic Nervous System

Co-author Network

Publications

TOP 3
Thomas Hedner; Krzysztof Narkiewicz; Suzanne Oparil; Sverre E Kjeldsen
Primary cardiovascular prevention by Mediterranean diet - The PREDIMED trial.
Per Torger Skretteberg; Kristian Engeseth; Gunnar Erikssen; Jan Erikssen; Knut Gjesdal; Irene Grundvold; Sverre E Kjeldsen; Knut Liestøl; Johan Bodegard
Seven-year increase in exercise systolic blood pressure at moderate workload predicts long-term risk of coronary heart disease and mortality in healthy middle-aged men.
Peter M Okin; Kristian Wachtell; Casper N Bang; Björn Dahlöf; Darcy A Hille; Sverre E Kjeldsen; Richard B Devereux
Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Sverre Kjeldsen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Thomas Hedner; Krzysztof Narkiewicz; Suzanne Oparil; Sverre E Kjeldsen
Primary cardiovascular prevention by Mediterranean diet - The PREDIMED trial.
Blood pressure 2013;22(3):129-30.
2013: Per Torger Skretteberg; Kristian Engeseth; Gunnar Erikssen; Jan Erikssen; Knut Gjesdal; Irene Grundvold; Sverre E Kjeldsen; Knut Liestøl; Johan Bodegard
Seven-year increase in exercise systolic blood pressure at moderate workload predicts long-term risk of coronary heart disease and mortality in healthy middle-aged men.
Hypertension 2013;61(5):1134-40.
2013: Peter M Okin; Kristian Wachtell; Casper N Bang; Björn Dahlöf; Darcy A Hille; Sverre E Kjeldsen; Richard B Devereux
Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy.
Circulation. Arrhythmia and electrophysiology 2013;6(2):243-51.
2013: Roland E Schmieder; Guido Grassi; Sverre E Kjeldsen
Patients with treatment-resistant hypertension report increased stress and anxiety: a worldwide study.
Journal of hypertension 2013;31(3):610-5; discussion 615.
2013: Felix Mahfoud; Sverre E Kjeldsen
Catheter-based renal denervation: a word of caution.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2013;8(9):.
2013: Erik Larsson; Bo Hedblad; Thomas Hedner; Sverre E Kjeldsen; Olle Melander; Björn Wahlstrand; Per Lindahl
Hypertension and genetic variation in endothelial-specific genes.
PloS one 2013;8(4):e62035.
2012: Sverre E Kjeldsen; Krzysztof Narkiewicz; Thomas Hedner; Suzanne Oparil
Angiotensin receptor--neprilysin inhibiton (ARNI)--a novel therapeutic concept for management of hypertension and heart failure.
Blood pressure 2012;21(6):329-30.
2012: Michael A Weber; Dion H Zappe; Hans R Brunner; Tsushung A Hua; Yan Jia; Stevo Julius; Sverre E Kjeldsen; Giuseppe Mancia; Gordon T McInnes; Anthony Schork; Alberto Zanchetti
Cardiovascular outcomes in hypertensive patients: comparing single-agent therapy with combination therapy.
Journal of hypertension 2012;30(11):2213-22.
2012: Sverre E Kjeldsen; Peter M Okin
High resting heart rate predicts mortality, disability, and cognitive decline in patients after ischaemic stroke: time for additional selective I(f) channel inhibitor trials?
European heart journal 2012;33(22):2761-3.
2012: Thomas Hedner; Krzysztof Narkiewicz; Suzanne Oparil; Sverre E Kjeldsen
Direct renin inhibitors in hypertension - approaching the moment of truth.
Blood pressure 2012;21(5):267-8.
2012: Sverre E Kjeldsen; Peter A Meredith; Franz H Messerli; Chern-En Chiang; Lisheng Liu
Are fixed-dose combination antihypertensives suitable as first-line therapy?
Current medical research and opinion 2012;28(10):1685-97.
2012: Anne Cecilie K Larstorp; Peter M Okin; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Kristian Wachtell
Regression of ECG-LVH is associated with lower risk of new-onset heart failure and mortality in patients with isolated systolic hypertension; The LIFE study.
American journal of hypertension 2012;25(10):1101-9.
2012: Anne Cecilie K Larstorp; Peter M Okin; Michael H Olsen; Inger Ariansen; Björn Dahlöf; Richard B Devereux; Knut Gjesdal; Hans Ibsen; Sverre E Kjeldsen; Kristian Wachtell
Association of pulse pressure with new-onset atrial fibrillation in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint (LIFE) reduction in hypertension study.
Hypertension 2012;60(2):347-53.
2012: Else C Sandset; Philip M W Bath; Eivind Berge; Sverre E Kjeldsen; Gordon D Murray
Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
Stroke; a journal of cerebral circulation 2012;43(8):2108-14.
2012: Irene Grundvold; Sverre E Kjeldsen; Knut Liestøl; Per Torger Skretteberg; Harald Arnesen; Gunnar Erikssen; Jan Erikssen; Knut Gjesdal; Johan Bodegard
Importance of physical fitness on predictive effect of body mass index and weight gain on incident atrial fibrillation in healthy middle-age men.
The American journal of cardiology 2012;110(3):425-32.
2012: Thomas Hedner; Sverre E Kjeldsen; Krzysztof Narkiewicz
State of global health--hypertension burden and control.
Blood pressure 2012;21 Suppl 1():1-2.
2012: Tonje A Aksnes; Sigrid N Skårn; Sverre E Kjeldsen
Treatment of hypertension in diabetes: what is the best therapeutic option?
Expert review of cardiovascular therapy 2012;10(6):727-34.
2012: Anne Christine H Ruwald; Thomas Sehestedt; Kristian Wachtell; Bo Westergaard; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Michael H Olsen
Losartan versus atenolol-based antihypertensive treatment reduces cardiovascular events especially well in elderly patients: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study.
Journal of hypertension 2012;30(6):1252-9.
2012: Peter M Okin; Björn Dahlöf; Sverre E Kjeldsen; Lars H Lindholm; Richard B Devereux
The relationship of electrocardiographic left ventricular hypertrophy to decreased serum potassium.
Blood pressure 2012;21(3):146-52.
2012: Johan Bodegard; Gunnar Erikssen; Knut Gjesdal; Sverre E Kjeldsen; Knut Liestøl; K Pyörälä; P T Skretteberg; Jan Erikssen
Low-grade systolic murmurs in healthy middle-aged individuals: innocent or clinically significant? A 35-year follow-up study of 2014 Norwegian men.
Journal of internal medicine 2012;271(6):581-8.
2012: Sverre E Kjeldsen; Peter M Okin
Prediction and prevention of atrial fibrillation in patients with high blood pressure or history of hypertension.
Journal of hypertension 2012;30(5):887-9.
2012: Roland E Schmieder; Philippe van de Borne; Guido Grassi; Sverre E Kjeldsen; Giuseppe Mancia; Krzysztof Narkiewicz; Gianfranco Parati; Josep Redon; Luis Ruilope; Costas Tsioufis
ESH position paper: renal denervation - an interventional therapy of resistant hypertension.
Journal of hypertension 2012;30(5):837-41.
2012: Peter M Okin; Björn Dahlöf; Darcy A Hille; Sverre E Kjeldsen; Richard B Devereux
Impact of lower achieved blood pressure on outcomes in hypertensive patients.
Journal of hypertension 2012;30(4):802-10; discussion 810.
2012: Peter M Okin; Björn Dahlöf; Stevo Julius; Sverre E Kjeldsen; Richard B Devereux
Racial differences in sudden cardiac death among hypertensive patients during antihypertensive therapy: the LIFE study.
Heart rhythm : the official journal of the Heart Rhythm Society 2012;9(4):531-7.
2012: Sverre E Kjeldsen; Jan Ostergren; Bertram Pitt; Jaakko Tuomilehto; Eric J Velazquez; Michael Weber; Dion Zappe; George L Bakris; Björn Dahlöf; Allen Hester; Tsushung A Hua; Hans Ibsen; Kenneth A Jamerson; Roxzana Y Kelly
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
Blood pressure 2012;21(2):82-7.
2012: Matthew R Weir; Jackson T Wright; George L Bakris; Bjorn Dahlof; Richard B Devereux; R Allen Hester; Tsushung A Hua; Roxzana Y Kelly; Sverre E Kjeldsen; Bertram Pitt; Eric Velazquez; Michael A Weber; Kenneth A Jamerson
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
Kidney international 2012;81(6):568-76.
2012: Stevo Julius; Sverre E Kjeldsen; Hans R Brunner; Bjoern Holzhauer; Tsushung A Hua; Kenneth A Jamerson; Silja Majahalme; Giuseppe Mancia; Gordon T McInnes; Paolo Palatini; M Anthony Schork; Michael A Weber; Alberto Zanchetti; Dion Zappe; Nevrez Koylan
Usefulness of heart rate to predict cardiac events in treated patients with high-risk systemic hypertension.
The American journal of cardiology 2012;109(5):685-92.
2012: Peter M Okin; Björn Dahlöf; Darcy A Hille; Stevo Julius; Sverre E Kjeldsen; Richard B Devereux
Effect of changing heart rate during treatment of hypertension on incidence of heart failure.
The American journal of cardiology 2012;109(5):699-704.
2012: Sverre E Kjeldsen; Krzysztof Narkiewicz; Thomas Hedner; Suzanne Oparil
Increased time varying heart rate and cardiovascular risk in hypertension: benefit of selective I((f)) channel inhibitor?
Blood pressure 2012;21(1):1-2.
2012: Irene Grundvold; Sverre E Kjeldsen; Knut Liestøl; Per Torger Skretteberg; Harald Arnesen; Gunnar Erikssen; Jan Erikssen; Johan Bodegard
Upper normal blood pressures predict incident atrial fibrillation in healthy middle-aged men: a 35-year follow-up study.
Hypertension 2012;59(2):198-204.
2012: Inger Ariansen; Björn Dahlöf; Richard B Devereux; Knut Gjesdal; Hans Ibsen; Sverre E Kjeldsen; Peter M Okin; Michael H Olsen; Henrik M Reims; Kristian Wachtell
Impact of alcohol habits and smoking on the risk of new-onset atrial fibrillation in hypertensive patients with ECG left ventricular hypertrophy: the LIFE study.
Blood pressure 2012;21(1):6-11.
2011: Nisha Mistry; Gunnar Smith; Sigrun Halvorsen; Pavel Hoffmann; Sverre E Kjeldsen; svend aakhus; Michael Abdelnoor; Jan Otto Beitnes; Reidar Bjørnerheim
Assessment of left ventricular function in ST-elevation myocardial infarction by global longitudinal strain: a comparison with ejection fraction, infarct size, and wall motion score index measured by non-invasive imaging modalities.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2011;12(9):678-83.
2011: Sverre E Kjeldsen; Krzysztof Narkiewicz; Suzanne Oparil; Thomas Hedner
High mortality explained by mildly elevated blood pressure in Scandinavian adolescent conscripts: a plea for early drug treatment?
Blood pressure 2011;20(4):188-9.
2011: Maciej Banach; Sverre E Kjeldsen; Jolanta Małyszko; Marta Michalska; Dimitri P Mikhailidis; Jacek Rysz
What should be the optimal levels of blood pressure: Does the J-curve phenomenon really exist?
Expert opinion on pharmacotherapy 2011;12(12):1835-44.
2011: Nisha Mistry; Michael Abdelnoor; Ingebjørg Seljeflot; Pavel Hoffmann; Ellen Bøhmer; Reidar Bjørnerheim; Sverre E Kjeldsen; Sigrun Halvorsen
Amino-terminal pro-B-type natriuretic peptide (NT-proBNP) levels 3 months after myocardial infarction are more strongly associated with magnetic resonance-determined ejection fraction than NTproBNP levels in the acute phase.
Journal of cardiac failure 2011;17(6):479-86.
2011: Camilla L Søraas; Theis Tønnessen; Sverre E Kjeldsen; Anne Cecilie K Larstorp; Arild Mangschau; Reidar Bjørnerheim
Echocardiographic demonstration of improved myocardial function early after coronary artery bypass graft surgery.
Interactive cardiovascular and thoracic surgery 2011;12(6):946-51.
2011: Michael H Olsen; Kristian Wachtell; Hans Ibsen; Lars Lindholm; Sverre E Kjeldsen; Per Omvik; Markku S Nieminen; Björn Dahlöf; Peter M Okin; Richard B Devereux
Changes in subclinical organ damage vs. in Framingham risk score for assessing cardiovascular risk reduction during continued antihypertensive treatment: a LIFE substudy.
Journal of hypertension 2011;29(5):997-1004.
2011: Sverre E Kjeldsen; Thomas Hedner; Krzysztof Narkiewicz; Suzanne Oparil
Treatment of high blood pressure in acute stroke--the SCAST study.
Blood pressure 2011;20(2):67-8.
2011: Christer Kubon; Nisha B Mistry; Irene Grundvold; Sigrun Halvorsen; Sverre E Kjeldsen; Arne S Westheim
The role of beta-blockers in the treatment of chronic heart failure.
Trends in pharmacological sciences 2011;32(4):206-12.
2011: Peter M Okin; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Sverre E Kjeldsen; Markku S Nieminen; Jonathan M Edelman; Björn Dahlöf; Richard B Devereux
Serial assessment of the electrocardiographic strain pattern for prediction of new-onset heart failure during antihypertensive treatment: the LIFE study.
European journal of heart failure 2011;13(4):384-91.
2011: David Russell; Jan Stålhammar; Johan Bodegard; Pål Hasvold; Marcus Thuresson; Sverre E Kjeldsen
Cardiovascular events in subgroups of patients during primary treatment of hypertension with candesartan or losartan.
Journal of clinical hypertension (Greenwich, Conn.) 2011;13(3):189-97.
2011: Peter M Okin; Sverre E Kjeldsen; Björn Dahlöf; Richard B Devereux
Racial differences in incident heart failure during antihypertensive therapy.
Circulation. Cardiovascular quality and outcomes 2011;4(2):157-64.
2011: A C K Larstorp; P M Okin; R B Devereux; M H Olsen; H Ibsen; B Dahlöf; Sverre E Kjeldsen; Kristian Wachtell
Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study.
Journal of human hypertension 2011;25(3):178-85.
2011: Sripal Bangalore; Sunil Kumar; Sverre E Kjeldsen; Harikrishna Makani; Ehud Grossman; Jørn Wetterslev; Ajay K Gupta; Peter S Sever; Christian Gluud; Franz H Messerli
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
The lancet oncology 2011;12(1):65-82.
2010: Maciej Banach; Sverre E Kjeldsen; Krzysztof Narkiewicz
Controversies in hypertension treatment.
Current vascular pharmacology 2010;8(6):731-2.
2010: Tonje A Aksnes; Sverre E Kjeldsen
A link between hypertension and atrial fibrillation: methods of treatment and prevention.
Current vascular pharmacology 2010;8(6):769-74.
2010: Sverre E Kjeldsen; Thomas Hedner; Suzanne Oparil; Krzysztof Narkiewicz
Angiotensin receptor blockers and cancer - Relationship dismissed by VALUE data while waiting for EMA and FDA reports.
Blood pressure 2010;19(5):271-2.
2010: Nisha Mistry; Sigrun Halvorsen; Pavel Hoffmann; Carl Müller; Ellen Bøhmer; Sverre E Kjeldsen; Reidar Bjørnerheim
Assessment of left ventricular function with magnetic resonance imaging vs. echocardiography, contrast echocardiography, and single-photon emission computed tomography in patients with recent ST-elevation myocardial infarction.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2010;11(9):793-800.
2010: Stevo Julius; Sverre E Kjeldsen; Michael A Weber
Angiotensin-receptor blockade, cancer, and concerns.
The lancet oncology 2010;11(9):820-1; author reply 821-2.
2010: Peter M Okin; Sverre E Kjeldsen; Stevo Julius; Darcy A Hille; Björn Dahlöf; Jonathan M Edelman; Richard B Devereux
All-cause and cardiovascular mortality in relation to changing heart rate during treatment of hypertensive patients with electrocardiographic left ventricular hypertrophy.
European heart journal 2010;31(18):2271-9.
2010: Suzanne Oparil; Sverre E Kjeldsen; Krzysztof Narkiewicz; Thomas Hedner
Blood pressure variability: Emerging role in risk assessment and therapeutics.
Blood pressure 2010;19(4):209-11.
2010: Benedicte P Wiik; Anne C K Larstorp; Aud Høieggen; Sverre E Kjeldsen; Michael Hecht Olsen; Hans Ibsen; Lars Lindholm; Björn Dahlöf; Richard B Devereux; Peter M Okin; Kristian Wachtell
Serum uric acid is associated with new-onset diabetes in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
American journal of hypertension 2010;23(8):845-51.
2010: Helga Gudmundsdottir; N C B B Taarnhøj; Arne Strand; Sverre E Kjeldsen; Aud Høieggen; Ingrid Os
Blood pressure development and hypertensive retinopathy: 20-year follow-up of middle-aged normotensive and hypertensive men.
Journal of human hypertension 2010;24(8):505-13.
2010: Nisha Mistry; Ellen Bøhmer; Pavel Hoffmann; Carl Müller; Reidar Bjørnerheim; Sverre E Kjeldsen; Sigrun Halvorsen
Left ventricular function in acute myocardial infarction treated with thrombolysis followed by early versus late invasive strategy.
American heart journal 2010;160(1):73-9.
2010: Michael H Olsen; Jean-Michel Mallion; Karl-Heinz Rahn; Serap Erdine; Margus Viigimaa; Stéphane Laurent; Enrico Agabiti-Rosei; Giuseppe Mancia; Roland E Schmieder; Renata Cifkova; Anna Dominiczak; Sverre E Kjeldsen; Josep Redon; Alberto Zanchetti; Peter Nilsson; Krzysztof Narkiewicz
Agreement within Europe about antihypertensive treatment and education - results from the European Society of Hypertension questionnaire.
Journal of hypertension 2010;28(7):1593-4.
2010: Peter M Okin; Darcy A Hille; Sverre E Kjeldsen; Lars H Lindholm; Jonathan M Edelman; Björn Dahlöf; Richard B Devereux
Greater regression of electrocardiographic left ventricular hypertrophy during hydrochlorothiazide therapy in hypertensive patients.
American journal of hypertension 2010;23(7):786-93.
2010: Michael A Weber; George L Bakris; Kenneth A Jamerson; Matthew R Weir; Sverre E Kjeldsen; Richard B Devereux; Eric J Velazquez; Björn Dahlöf; Roxzana Y Kelly; Tsushung Hua; Allen Hester; Bertram Pitt
Cardiovascular events during differing hypertension therapies in patients with diabetes.
Journal of the American College of Cardiology 2010;56(1):77-85.
2010: Silvana Cicala; Giovanni de Simone; Eva Gerdts; Björn Dahlöf; Lars H Lindholm; Sverre E Kjeldsen; Richard B Devereux
Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2010;28(6):1134-40.
2010: Sverre E Kjeldsen; Thomas Hedner; Krzysztof Narkiewicz; Suzanne Oparil
Blood Pressure celebrates 20 years of dedication to Nordic hypertension research.
Blood pressure 2010;19(3):130-1.
2010: Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
The prognostic significance of heart rate for cardiovascular disease and hypertension.
Current hypertension reports 2010;12(3):162-9.
2010: Camilla L Søraas; Kristian Wachtell; Peter M Okin; Björn Dahlöf; Richard B Devereux; Theis Tønnessen; Sverre E Kjeldsen; Michael H Olsen
Lack of regression of left ventricular hypertrophy is associated with higher incidence of revascularization in hypertension: The LIFE Study.
Blood pressure 2010;19(3):145-51.
2010: Markus P Schneider; Tsushung Hua; Michael Böhm; Kristian Wachtell; Sverre E Kjeldsen; Roland E Schmieder
Prevention of atrial fibrillation by Renin-Angiotensin system inhibition a meta-analysis.
Journal of the American College of Cardiology 2010;55(21):2299-307.
2010: Sverre E Kjeldsen; Roland E Schmieder; Thomas Unger; Giuseppe Mancia
Telmisartan and hydrochlorothiazide combination therapy for the treatment of hypertension.
Current medical research and opinion 2010;26(4):879-87.
2010: Sverre E Kjeldsen; J Stålhammar; P Hasvold; Johan Bodegard; U Olsson; D Russell
Effects of losartan vs candesartan in reducing cardiovascular events in the primary treatment of hypertension.
Journal of human hypertension 2010;24(4):263-73.
2010: Per Torger Skretteberg; Johan Bodegård; Sverre E Kjeldsen; Gunnar Erikssen; Erik Thaulow; Leif Sandvik; Jan E Erikssen
Interaction between inflammation and blood viscosity predicts cardiovascular mortality.
Scandinavian cardiovascular journal : SCJ 2010;44(2):107-12.
2010: Skjalg S Hassellund; Arnljot Flaa; Leiv Sandvik; Sverre E Kjeldsen; Morten Rostrup
Long-term stability of cardiovascular and catecholamine responses to stress tests: an 18-year follow-up study.
Hypertension 2010;55(1):131-6.
2009: Maciej Banach; Dimitri P Mikhailidis; Sverre E Kjeldsen; Jacek Rysz
Time for new indications for statins?
Medical science monitor : international medical journal of experimental and clinical research 2009;15(12):MS1-5.
2009: Daniel P Morin; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Markku S Nieminen; Sverre E Kjeldsen; Björn Dahlöf; Majnu John; Richard B Devereux; Peter M Okin
QRS duration predicts sudden cardiac death in hypertensive patients undergoing intensive medical therapy: the LIFE study.
European heart journal 2009;30(23):2908-14.
2009: Peter M Okin; Richard B Devereux; Sverre E Kjeldsen; Jonathan M Edelman; Björn Dahlöf
Incidence of heart failure in relation to QRS duration during antihypertensive therapy: the LIFE study.
Journal of hypertension 2009;27(11):2271-7.
2009: Giovanni de Simone; Peter M Okin; Eva Gerdts; M H Olsen; Kristian Wachtell; Darcy A Hille; Björn Dahlöf; Sverre E Kjeldsen; Richard B Devereux
Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(9):634-40.
2009: Steinar Madsen; Bjørn Gjelsvik; Sverre E Kjeldsen; Tor Ole Klemsdal; Eivind Meland; Stein Narvesen; Ole Frithjof Norheim; Inger Njølstad; Serena Tonstad; Frøydis Ulvin
[Solid guidelines for prevention of cardiovascular diseases].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2009;129(16):1660.
2009: Mariusz Stepien; Maciej Banach; Dimitri P Mikhailidis; Anna Gluba; Sverre E Kjeldsen; Jacek Rysz
Role and significance of statins in the treatment of hypertensive patients.
Current medical research and opinion 2009;25(8):1995-2005.
2009: Trygve B Tjugen; Arnljot Flaa; Sverre E Kjeldsen
High heart rate as predictor of essential hypertension: the hyperkinetic state, evidence of prediction of hypertension, and hemodynamic transition to full hypertension.
Progress in cardiovascular diseases 2009;52(1):20-5.
2009: Peter M Okin; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Sverre E Kjeldsen; Markku S Nieminen; Jonathan Edelman; Björn Dahlöf; Richard B Devereux
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
Circulation 2009;119(14):1883-91.
2009: Alberto Zanchetti; Giuseppe Mancia; Henry R Black; Suzanne Oparil; Bernard Waeber; Roland E Schmieder; George L Bakris; Franz H Messerli; Sverre E Kjeldsen; Luis M Ruilope
Facts and fallacies of blood pressure control in recent trials: implications in the management of patients with hypertension.
Journal of hypertension 2009;27(4):673-9.
2009: Michael H Olsen; Kristian Wachtell; Gareth Beevers; Björn Dahlöf; Giovanni de Simone; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2009;27(3):567-74.
2009: Thomas Hedner; Suzanne Oparil; Krzysztof Narkiewicz; Sverre E Kjeldsen
The J-curve phenomenon revisited.
Blood pressure 2009;18(4):168-70.
2009: Tonje A Aksnes; Sverre E Kjeldsen; Roland E Schmieder
Hypertension and atrial fi brillation with emphasis on prevention.
Blood pressure 2009;18(3):94-8.
2009: Sverre E Kjeldsen; Richard B Devereux; Darcy A Hille; Paulette A Lyle; Björn Dahlöf; Stevo Julius; Jonathan M Edelman; Steven M Snapinn; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study.
Blood pressure 2009;18(6):348-61.
2009: Sverre E Kjeldsen; Suzanne Oparil; Krzysztof Narkiewicz; Thomas Hedner
Should we treat prehypertension?
Blood pressure 2009;18(6):298-9.
2009: Sverre E Kjeldsen; Krzysztof Narkiewicz; Thomas Hedner
The surge of Japanese studies supporting the use of angiotensin receptor blockers in hypertension.
Blood pressure 2009;18(5):240-1.
2009: Walter Zidek; Lisa Naditch-Brûlé; Stefano Perlini; Csaba Farsang; Sverre E Kjeldsen
Blood pressure control and components of the metabolic syndrome: the GOOD survey.
Cardiovascular diabetology 2009;8():51.
2009: Sverre E Kjeldsen; Suzanne Oparil; Thomas Hedner; Krzysztof Narkiewicz
Does GISSI-AF change the concept of using RAS inhibitors in the primary prevention of atrial fibrillation in hypertensive patients?
Blood pressure 2009;18(3):92-3.
2009: Suzanne Oparil; Sverre E Kjeldsen; Thomas Hedner; Krzysztof Narkiewicz
ONTARGET, TRANSCEND and PROFESS--clarifying, confusing or misleading?
Blood pressure 2009;18(1-2):4-6.
2008: Peter M Okin; Kristian Wachtell; Sverre E Kjeldsen; Stevo Julius; Lars H Lindholm; Björn Dahlöf; Darcy A Hille; Markku S Nieminen; Jonathan M Edelman; Richard B Devereux
Incidence of atrial fibrillation in relation to changing heart rate over time in hypertensive patients: the LIFE study.
Circulation. Arrhythmia and electrophysiology 2008;1(5):337-43.
2008: Thomas Hedner; Sverre E Kjeldsen; Krzysztof Narkiewicz; Susanne Oparil
More focus on therapeutic targets and improved tolerability in hypertension.
Blood pressure. Supplement 2008;2():3-4.
2008: Helga Gudmundsdottir; Arne Strand; Sverre E Kjeldsen; Aud Høieggen; Ingrid Os
Serum phosphate, blood pressure, and the metabolic syndrome--20-year follow-up of middle-aged men.
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(11):814-21.
2008: Jan Ostergren; Neil R Poulter; Peter S Sever; Björn Dahlöf; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien
The Anglo-Scandinavian Cardiac Outcomes Trial: blood pressure-lowering limb: effects in patients with type II diabetes.
Journal of hypertension 2008;26(11):2103-11.
2008: Sverre E Kjeldsen; Lisa Naditch-Brule; Stefano Perlini; Walter Zidek; Csaba Farsang
Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
Journal of hypertension 2008;26(10):2064-70.
2008: Arnljot Flaa; Tonje Amb Aksnes; Sverre E Kjeldsen; Ivar Eide; Morten Rostrup
Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study.
Metabolism: clinical and experimental 2008;57(10):1422-7.
2008: Arnljot Flaa; Ivar Eide; Sverre E Kjeldsen; Morten Rostrup
Sympathoadrenal stress reactivity is a predictor of future blood pressure: an 18-year follow-up study.
Hypertension 2008;52(2):336-41.
2008: Tonje Amb Aksnes; Sverre E Kjeldsen; M Rostrup; O Störset; Tsushung Hua; Stevo Julius
Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial.
Journal of human hypertension 2008;22(8):520-7.
2008: Peter M Okin; Eva Gerdts; Sverre E Kjeldsen; Stevo Julius; Jonathan Edelman; Björn Dahlöf; Richard B Devereux
Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
Hypertension 2008;52(1):100-6.
2008: Tonje Amb Aksnes; Arnljot Flaa; Arne Strand; Sverre E Kjeldsen
Prevention of atrial fibrillation in hypertension.
Current hypertension reports 2008;10(3):175-81.
2008: Thomas Hedner; Suzanne Oparil; Krzysztof Narkiewicz; Sverre E Kjeldsen
Achieving better blood pressure control.
Blood pressure. Supplement 2008;1():3-4.
2008: Arnljot Flaa; Leiv Sandvik; Sverre E Kjeldsen; Ivar Eide; Morten Rostrup
Does sympathoadrenal activity predict changes in body fat? An 18-y follow-up study.
The American journal of clinical nutrition 2008;87(6):1596-601.
2008: Zhibin Li; Björn Dahlöf; Peter M Okin; Sverre E Kjeldsen; Kristian Wachtell; Hans Ibsen; Markku S Nieminen; Sverker Jern; Richard B Devereux
Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
Journal of hypertension 2008;26(6):1244-9.
2008: Ingrid Os; Veronica Franco; Sverre E Kjeldsen; Karin Manhem; Richard B Devereux; Eva Gerdts; Darcy A Hille; Paulette A Lyle; Peter M Okin; Björn Dahlöf; Suzanne Oparil
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Hypertension 2008;51(4):1103-8.
2008: Roland E Schmieder; Sverre E Kjeldsen; Stevo Julius; Gordon T McInnes; Alberto Zanchetti; Tsushung Hua
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial.
Journal of hypertension 2008;26(3):403-11.
2008: Peter M Okin; Kristian Wachtell; Richard B Devereux; Markku S Nieminen; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Sverre E Kjeldsen; Stevo Julius; Björn Dahlöf
Combination of the electrocardiographic strain pattern and albuminuria for the prediction of new-onset heart failure in hypertensive patients: the LIFE study.
American journal of hypertension 2008;21(3):273-9.
2008: Renata Cífková; Giuseppe Mancia; Sverre E Kjeldsen; Stephane Laurent
European guidelines on cardiovascular disease prevention in clinical practice: past, present, and future: a need for joint forces.
Journal of hypertension 2008;26(2):157-60.
2008: Peter S Sever; Neil R Poulter; Bjorn Dahlof; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku S Nieminen; Eoin T O'Brien; Jan Ostergren
The Anglo-Scandinavian Cardiac Outcomes Trial lipid lowering arm: extended observations 2 years after trial closure.
European heart journal 2008;29(4):499-508.
2008: Sverre E Kjeldsen; Thomas Hedner; Krzystof Narkiewicz; Suzanne Oparil
More is less? Optimal combination therapy for adequate blood pressure lowering in hypertension.
Blood pressure 2008;17(3):132-3.
2008: Sverre E Kjeldsen; Gordon T McInnes; Giuseppe Mancia; Tsushung Hua; Stevo Julius; Michael A Weber; Antonio Coca; Xavier Girerd; Kenneth A Jamerson; Pierre Larochelle; Thomas Macdonald; Roland E Schmieder; M Anthony Schork; Reuven Viskoper; Jiri Widimsky; Alberto Zanchetti
Progressive effects of valsartan compared with amlodipine in prevention of diabetes according to categories of diabetogenic risk in hypertensive patients: the VALUE trial.
Blood pressure 2008;17(3):170-7.
2008: Helga Gudmundsdottir; Arne H Strand; Aud Høieggen; Henrik M Reims; Arne S Westheim; Ivar Eide; Sverre E Kjeldsen; Ingrid Os
Do screening blood pressure and plasma catecholamines predict development of hypertension? Twenty-year follow-up of middle-aged men.
Blood pressure 2008;17(2):94-103.
2008: Sverre E Kjeldsen; Suzanne Oparil; Krzysztof Narkiewicz; Thomas Hedner
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Blood pressure 2008;17(2):68-9.
2008: Sverre E Kjeldsen; Kenneth A Jamerson; George L Bakris; Bertram Pitt; Björn Dahlöf; Eric Velazquez; Jitendra Gupte; Linda Staikos; Tsushung Hua; Victor Shi; Allen Hester; Jaakko Tuomilehto; Jan Ostergren; Hans Ibsen; Michael Weber
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
Blood pressure 2008;17(1):7-17.
2008: Thomas Hedner; Sverre E Kjeldsen; Krzysztof Narkiewicz; Suzanne Oparil
Urgent need to address quality control issues of out-of-office blood pressure measurement and patient risk assessment.
Blood pressure 2008;17(1):5-6.
2008: Arne Strand; Sverre E Kjeldsen; Helga Gudmundsdottir; Ingrid Os; G Smith; Reidar Bjørnerheim
Tissue Doppler imaging describes diastolic function in men prone to develop hypertension over twenty years.
European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology 2008;9(1):34-9.
2007: Arne Strand; Helga Gudmundsdottir; Aud Høieggen; Eigil Fossum; Reidar Bjørnerheim; Ingrid Os; Sverre E Kjeldsen
Increased hematocrit before blood pressure in men who develop hypertension over 20 years.
Journal of the American Society of Hypertension : JASH 2007;1(6):400-6.
2007: Tonje Amb Aksnes; Ingebjørg Seljeflot; Peter A Torjesen; Aud Höieggen; andreas moan; Sverre E Kjeldsen
Improved insulin sensitivity by the angiotensin II-receptor blocker losartan is not explained by adipokines, inflammatory markers, or whole blood viscosity.
Metabolism: clinical and experimental 2007;56(11):1470-7.
2007: Peter M Okin; Richard B Devereux; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Lars H Lindholm; Björn Dahlöf
In-treatment resolution or absence of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) Study.
Hypertension 2007;50(5):984-90.
2007: Thomas Hedner; Krzysztof Narkiewicz; Sverre E Kjeldsen
The evolution of ACE inhibition--a turning point in cardiovascular medicine.
Blood pressure. Supplement 2007;2():5-6.
2007: Eigil Fossum; Gilbert W Gleim; Sverre E Kjeldsen; Jorge R Kizer; Stevo Julius; Richard B Devereux; W E Brady; Darcy A Hille; Paulette A Lyle; Björn Dahlöf
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.
Journal of internal medicine 2007;262(4):439-48.
2007: Peter M Okin; Richard B Devereux; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Jonathan Edelman; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy is associated with less hospitalization for heart failure in hypertensive patients.
Annals of internal medicine 2007;147(5):311-9.
2007: Giuseppe Mancia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis M Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry Aj Struijker Boudier; Alberto Zanchetti
2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension.
Journal of hypertension 2007;25(9):1751-62.
2007: Marianne L Smebye; Emil K Iversen; Aud Høieggen; Arnljot Flaa; Ingrid Os; Sverre E Kjeldsen; Michael H Olsen; Arghya Chattopadhyay; Darcy A Hille; Paulette A Lyle; Richard B Devereux; Björn Dahlöf
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).
The American journal of cardiology 2007;100(5):855-9.
2007: Tonje Amb Aksnes; Sverre E Kjeldsen; Morten Rostrup; Per Omvik; Tsushung Hua; Stevo Julius
Impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial population.
Hypertension 2007;50(3):467-73.
2007: Kristian Wachtell; Peter M Okin; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Hans Ibsen; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Kristian Thygesen
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
Circulation 2007;116(7):700-5.
2007: Giovanni de Simone; Michael H Olsen; Kristian Wachtell; Darcy A Hille; Björn Dahlöf; Hans Ibsen; Sverre E Kjeldsen; Paulette A Lyle; Richard B Devereux
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
Journal of human hypertension 2007;21(8):625-32.
2007: Arnljot Flaa; Tonje Amb Aksnes; Arne Strand; Sverre E Kjeldsen
Complications of hypertension and the role of angiotensin receptor blockers in hypertension trials.
Expert review of cardiovascular therapy 2007;5(3):451-61.
2007: Arne Strand; Helga Gudmundsdottir; Eigil Fossum; Ingrid Os; Reidar Bjørnerheim; Sverre E Kjeldsen
Arterial plasma vasopressin and aldosterone predict left ventricular mass in men who develop hypertension over 20 years.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(5):365-71.
2007: Hilde Marie Angell Eid; Henrik M Reims; Harald Arnesen; Sverre E Kjeldsen; Torstein Lyberg; Ingebjørg Seljeflot
Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.
Metabolism: clinical and experimental 2007;56(4):464-9.
2007: Thomas Hedner; Krzysztof Narkiewicz; Sverre E Kjeldsen
There is a need for more aggressive implementation of combination strategies to control hypertensive risk.
Blood pressure. Supplement 2007;1():4-5.
2007: Ole Lederballe Pedersen; Giuseppe Mancia; Thomas Pickering; Asbjørn Høegholm; Stevo Julius; Sverre E Kjeldsen; Eric S Nielsen; Jens Refsgaard; Michael Weber
Ambulatory blood pressure monitoring after 1 year on valsartan or amlodipine-based treatment: a VALUE substudy.
Journal of hypertension 2007;25(3):707-12.
2007: Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Katherine E Harris; Hans Ibsen; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Darcy A Hille; Björn Dahlöf
Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
Current medical research and opinion 2007;23(2):259-70.
2007: Sverre E Kjeldsen; Suzanne Oparil; Krzysztof Narkiewicz; Thomas Hedner
Ambulatory blood pressure adds to explaining benefits of AT-1 receptor blockade in the treatment of left ventricular hypertrophy.
Blood pressure 2007;16(6):344-6.
2007: Krzysztof Narkiewicz; Sverre E Kjeldsen; Suzanne Oparil; Thomas Hedner
Hypertension and cardiovascular disease: is arterial stiffness the heart of the matter?
Blood pressure 2007;16(4):236-7.
2007: Giuseppe Mansia; Guy De Backer; Anna Dominiczak; Renata Cifkova; Robert Fagard; Giuseppe Germano; Guido Grassi; Anthony M Heagerty; Sverre E Kjeldsen; Stephane Laurent; Krzysztof Narkiewicz; Luis M Ruilope; Andrzej Rynkiewicz; Roland E Schmieder; Harry A J Struijker Boudier; Alberto Zanchetti
2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Blood pressure 2007;16(3):135-232.
2007: Thomas Hedner T; Krzysztof Narkiewicz; Sverre E Kjeldsen; Suzanne Oparil
New ESH/ESC guidelines signal progress in hypertension management.
Blood pressure 2007;16(3):132-4.
2007: Sverre E Kjeldsen; Paulette A Lyle; Jorge R Kizer; Suzanne Oparil; Aud Høieggen; Ingrid Os
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.
Vascular health and risk management 2007;3(3):299-305.
2007: Kenneth A Jamerson; George L Bakris; Björn Dahlöf; Bertram Pitt; Eric Velazquez; Jitendra Gupte; Martin Lefkowitz; Allen Hester; Victor Shi; Sverre E Kjeldsen; William Cushman; Vasilios Papademetriou; Michael Weber
Exceptional early blood pressure control rates: the ACCOMPLISH trial.
Blood pressure 2007;16(2):80-6.
2007: Luis M Ruilope; Sverre E Kjeldsen; Alejandro de la Sierra; Giuseppe Mancia; Piero Ruggenenti; George S Stergiou; George L Bakris; Thomas D Giles
The kidney and cardiovascular risk--implications for management: a consensus statement from the European Society of Hypertension.
Blood pressure 2007;16(2):72-9.
2007: Thomas Hedner; Sverre E Kjeldsen; Krzysztof Narkiewicz; Susanne Oparil
Blood pressure control--slowly getting there through new strategies?
Blood pressure 2007;16(2):68-71.
2007: Michael A Weber; George L Bakris; Björn Dahlöf; Bertram Pitt; Eric Velazquez; Jitendra Gupte; Martin Lefkowitz; Allen Hester; Victor Shi; Matthew R Weir; Sverre E Kjeldsen; Barrie Massie; Shawna Nesbitt; Elizabeth Ofili; Kenneth A Jamerson
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
Blood pressure 2007;16(1):13-9.
2007: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Paulette A Lyle; Zhongxin Zhang; Jonathan Edelman
Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
Blood pressure 2007;16(1):6-12.
2007: Sverre E Kjeldsen; Suzanne Oparil; Thomas Hedner; Krzysztof Narkiewicz
Documentation of endpoint prevention with combination therapy in hypertension is urgently needed.
Blood pressure 2007;16(1):4-5.
2007: Arnljot Flaa; Oivind Ekeberg; Sverre E Kjeldsen; Morten Rostrup
Personality may influence reactivity to stress.
BioPsychoSocial medicine 2007;1():5.
2007: Gisli Jonsson; Michael Abdelnoor; Ingebjørg Seljeflot; Harald Arnesen; Arne T Hostmark; Sverre E Kjeldsen; Ingrid Os; Arne Westheim
The antioxidative effects of long-term treatment are more pronounced for carvedilol than for atenolol in post-myocardial infarction patients.
Journal of cardiovascular pharmacology 2007;49(1):27-32.
2007: Tonje Amb Aksnes; Arnljot Flaa; Arne Strand; Sverre E Kjeldsen
Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure.
Journal of hypertension 2007;25(1):15-23.
2006: Peter S Sever; Björn Dahlöf; Neil Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminem; Eoin O'Brien; Jan Ostergren
Potential synergy between lipid-lowering and blood-pressure-lowering in the Anglo-Scandinavian Cardiac Outcomes Trial.
European heart journal 2006;27(24):2982-8.
2006: Anne Cecilie K Larstorp; Camilla Lund Søraas; Theis Tønnessen; Carl Müller; Sverre E Kjeldsen; Arild Mangschau
Scintigraphic demonstration of myocardial perfusion and ischaemia associated with coronary artery bypass grafting.
Scandinavian cardiovascular journal : SCJ 2006;40(6):354-62.
2006: Peter M Nilsson; Renata Cifkova; Sverre E Kjeldsen; Guiseppe Mancia
European Society of Hypertension Scientific Newsletter: update on hypertension management: prevention of type 2 diabetes mellitus with antihypertensive drugs.
Journal of hypertension 2006;24(12):2478-82.
2006: Alberto Zanchetti; Stevo Julius; Sverre E Kjeldsen; Gordon T McInnes; Tsushung Hua; Michael Weber; John H Laragh; Francis Plat; Edouard Battegay; Cesar Calvo-Vargas; Andrzej Cieśliński; Jean-Paul Degaute; Nicolaas J Holwerda; Janna Kobalava; Ole Lederballe Pedersen; Faustinus P Rudyatmoko; Kostas Siamopoulos; Oyvind Störset
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: An analysis of findings from the VALUE trial.
Journal of hypertension 2006;24(11):2163-8.
2006: Tonje Amb Aksnes; Henrik M Reims; S Guptha; andreas moan; Ingrid Os; Sverre E Kjeldsen
Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
Journal of human hypertension 2006;20(11):860-6.
2006: Peter M Okin; Kristian Wachtell; Richard B Devereux; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Lars H Lindholm; Markku S Nieminen; Jonathan Edelman; Darcy A Hille; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension.
JAMA : the journal of the American Medical Association 2006;296(10):1242-8.
2006: Stevo Julius; Michael A Weber; Sverre E Kjeldsen; Gordon T McInnes; Alberto Zanchetti; Hans R Brunner; John H Laragh; M Anthony Schork; Tsushung Hua; John Amerena; Ivan Balazovjech; Graham Cassel; Bela Herczeg; Nevrez Koylan; Dieter Magometschnigg; Silja Majahalme; Felipe Martinez; Willie Oigman; Ricardo Seabra-Gomes; Jun-ren Zhu
The Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial: outcomes in patients receiving monotherapy.
Hypertension 2006;48(3):385-91.
2006: Michael H Olsen; Kristian Wachtell; Olav Wendelboe Nielsen; Christian Hall; Ragnhild Wergeland; Hans Ibsen; Sverre E Kjeldsen; Richard B Devereux; Björn Dahlöf; Per R Hildebrandt
N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
Journal of hypertension 2006;24(8):1531-9.
2006: Sverre E Kjeldsen; Arne Strand; Stevo Julius; Peter M Okin
Mechanism of angiotensin II type 1 receptor blocker action in the regression of left ventricular hypertrophy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(7):487-92.
2006: Sverre E Kjeldsen; Stevo Julius; Giuseppe Mancia; Gordon T McInnes; Tsushung Hua; Michael A Weber; Antonio Coca; Steffan Ekman; Xavier Girerd; Kenneth A Jamerson; Pierre Larochelle; Thomas M MacDonald; Roland E Schmieder; M Anthony Schork; Pelle Stolt; Reuven Viskoper; Jiri Widimský; Alberto Zanchetti
Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.
Journal of hypertension 2006;24(7):1405-12.
2006: Ingrid Os; Helga Gudmundsdottir; Sverre E Kjeldsen; Suzanne Oparil
Treatment of isolated systolic hypertension in diabetes mellitus type 2.
Diabetes, obesity & metabolism 2006;8(4):381-7.
2006: Serap Erdine; Oben Ari; Alberto Zanchetti; Renata Cifkova; R Fagard; Sverre E Kjeldsen; Giuseppe Mancia; Neil Poulter; K H Rahn; J L Rodicio; Luis M Ruilope; J Staessen; P van Zwieten; B Waeber; B Williams
ESH-ESC guidelines for the management of hypertension.
Herz 2006;31(4):331-8.
2006: Arnljot Flaa; Sverre E Kjeldsen
Are all the hypertensives made equal?
Herz 2006;31(4):323-30.
2006: Arne Strand; Helga Gudmundsdottir; Ingrid Os; Gunnar Smith; Arne Westheim; Reidar Bjørnerheim; Sverre E Kjeldsen
Arterial plasma noradrenaline predicts left ventricular mass independently of blood pressure and body build in men who develop hypertension over 20 years.
Journal of hypertension 2006;24(5):905-13.
2006: Nisha B Mistry; Arne Westheim; Sverre E Kjeldsen
The angiotensin receptor antagonist valsartan: a review of the literature with a focus on clinical trials.
Expert opinion on pharmacotherapy 2006;7(5):575-81.
2006: Michael H Olsen; Kristian Wachtell; Hans Ibsen; Lars H Lindholm; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Lasse Oikarinen; Peter M Okin
Reductions in albuminuria and in electrocardiographic left ventricular hypertrophy independently improve prognosis in hypertension: the LIFE study.
Journal of hypertension 2006;24(4):775-81.
2006: Paolo Palatini; ATHANASE BENETOS; Guido Grassi; Stevo Julius; Sverre E Kjeldsen; Giuseppe Mancia; Krzystof Narkiewicz; Gianfranco Parati; Achille C Pessina; Luis M Ruilope; Alberto Zanchetti
Identification and management of the hypertensive patient with elevated heart rate: statement of a European Society of Hypertension Consensus Meeting.
Journal of hypertension 2006;24(4):603-10.
2006: Peter M Okin; Richard B Devereux; Eva Gerdts; Steven M Snapinn; Katherine E Harris; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Jonathan Edelman; Lars H Lindholm; Björn Dahlöf
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.
Circulation 2006;113(12):1588-96.
2006: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Sverre E Kjeldsen; Hans Ibsen; Ying Wan; Stevo Julius
Long-term effects of a losartan- compared with an atenolol-based treatment regimen on carotid artery plaque development in hypertensive patients with left ventricular hypertrophy: ICARUS, a LIFE substudy.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(3):169-73.
2006: Arnljot Flaa; Håvard H Mundal; Ivar Eide; Sverre E Kjeldsen; Morten Rostrup
Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges.
Hypertension 2006;47(3):396-402.
2006: Thomas Hedner; Sverre E Kjeldsen; Krzysztof Narkiewicz
RAAS inhibition--a practice of medical progress.
Blood pressure. Supplement 2006;1():5-6.
2006: Peter M Okin; Richard B Devereux; Markku S Nieminen; Sverker Jern; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Sverre E Kjeldsen; Björn Dahlöf
Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.
Circulation 2006;113(1):67-73.
2006: Krzysztof Narkiewicz; Sverre E Kjeldsen; Suzanne Oparil; Thomas Hedner
Beta-blockers as sub-optimal treatment for hypertension: time for first-line therapy revision?
Blood pressure 2006;15(6):323-4.
2006: Thomas Hedner; Krzysztof Narkiewicz; Suzanne Oparil; Sverre E Kjeldsen
The question of whether diabetes and its cardiovascular risks can be prevented: a realistic DREAM?
Blood pressure 2006;15(5):260-2.
2006: Peter M Nilsson; Renata Cifkova; Sverre E Kjeldsen; Giuseppe Mancia
Prevention of type 2 diabetes mellitus with antihypertensive drugs.
Blood pressure 2006;15(4):253-4.
2006: Marina K Christensen; Michael H Olsen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Niels Wiinberg; Richard B Devereux; Sverre E Kjeldsen; Per Hildebrandt; Jens Rokkedal; Hans Ibsen
Does long-term losartan- vs atenolol-based antihypertensive treatment influence collagen markers differently in hypertensive patients? A LIFE substudy.
Blood pressure 2006;15(4):198-206.
2006: Thomas Hedner; Krzysztof Narkiewicz; Sverre E Kjeldsen
Medical decision making in hypertension.
Blood pressure 2006;15(4):196-7.
2006: Sverre E Kjeldsen; Krzysztof Narkiewicz; Thomas Hedner
An American TROPHY in the prevention of hypertension.
Blood pressure 2006;15(3):132-4.
2006: Nisha B Mistry; Arne Westheim; Sverre E Kjeldsen
Treatment of hypertension in patients with congestive cardiac failure.
Heart failure monitor 2006;5(2):38-43.
2006: Tonje Amb Aksnes; Sverre E Kjeldsen; Giuseppe Mancia
The effect of antihypertensive agents on new-onset diabetes mellitus: time to amend the guidelines?
American journal of cardiovascular drugs : drugs, devices, and other interventions 2006;6(3):139-47.
2006: Sverre E Kjeldsen; Karl Knudsen; Gunhild Ekrem; Tormod O Fure; Petter Movinckel; Jan Erikssen
Is there an association between severe job strain, transient rise in blood pressure and increased mortality?
Blood pressure 2006;15(2):93-100.
2006: Krzysztof Narkiewicz; Sverre E Kjeldsen; Thomas Hedner
Hypertension and cardiovascular disease in women: progress towards better understanding of gender-specific differences?
Blood pressure 2006;15(2):68-70.
2006: Gisli Jonsson; Michael Abdelnoor; Sverre Landaas; Carl Muller; Sverre E Kjeldsen; Ingrid Os; Arne Westheim
N-terminal pro-B-type natriuretic peptide in risk stratification after acute myocardial infarction in patients on long-term beta-adrenergic receptor blocker therapy.
Cardiology 2006;106(2):102-8.
2006: peter M Nilsson; Renata Cifkova; Sverre E Kjeldsen
Treatment of Hypertension in patients with type-2 diabetes mellitus.
Blood pressure 2006;15(1):62-3.
2006: Thomas Hedner; Krzysztof Narkiewicz; Sverre E Kjeldsen
Cost-effectiveness of blood pressure measurement and hypertension follow-up.
Blood pressure 2006;15(1):4-5.
2006: Peter M Nilsson; Renata Cifkova; Sverre E Kjeldsen
Update on Hypertension Management: treatment of hypertension in patients with type 2 diabetes mellitus.
Journal of hypertension 2006;24(1):208-10.
2006: Sverre E Kjeldsen; Krzysztof Narkiewicz; Renata Cífková; Giuseppe Mancia
ESH statement on detection and punishment of abstract fraud and poster plagiarism.
Journal of hypertension 2006;24(1):203-4.
2005: Sverre E Kjeldsen; Arne Westheim; Ingrid Os
More heat to support aggressive blood pressure lowering: the FEVER study.
Journal of hypertension 2005;23(12):2145-6.
2005: Sverre E Kjeldsen; Paulette A Lyle; Andrew M Tershakovec; Richard B Devereux; Suzanne Oparil; Björn Dahlöf; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Hans Wedel
Targeting the renin-angiotensin system for the reduction of cardiovascular outcomes in hypertension: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Expert opinion on emerging drugs 2005;10(4):729-45.
2005: Neil R Poulter; Hans Wedel; Björn Dahlöf; Peter S Sever; D Gareth Beevers; Mark Caulfield; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren; Stuart Pocock
Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA).
Lancet 2005;366(9489):907-13.
2005: Björn Dahlöf; Peter S Sever; Neil R Poulter; Hans Wedel; D Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial.
Lancet 2005;366(9489):895-906.
2005: Eigil Fossum; andreas moan; Sverre E Kjeldsen; Richard B Devereux; Stevo Julius; Steven M Snapinn; Jonathan Edelman; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Björn Dahlöf
The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension taking aspirin: the Losartan Intervention for Endpoint Reduction in hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;46(5):770-5.
2005: Stanley S Franklin; Kristian Wachtell; Vasilios Papademetriou; Michael H Olsen; Richard B Devereux; Frej Fyhrquist; Hans Ibsen; Sverre E Kjeldsen; Björn Dahlöf
Cardiovascular morbidity and mortality in hypertensive patients with lower versus higher risk: a LIFE substudy.
Hypertension 2005;46(3):492-9.
2005: Tonje Amb Aksnes; Henrik M Reims; Sverre E Kjeldsen; Giuseppe Mancia
Antihypertensive treatment and new-onset diabetes mellitus.
Current hypertension reports 2005;7(4):298-303.
2005: Thomas Hedner; Krzysztof Narkiewicz; Sverre E Kjeldsen
Hypertension control- A global challenge.
Blood pressure. Supplement 2005;1():4-5.
2005: Henrik M Reims; Sverre E Kjeldsen; Giuseppe Mancia
Home blood pressure monitoring.
Journal of hypertension 2005;23(7):1437-9.
2005: Sverre E Kjeldsen; Arne Westheim; Ingrid Os
Prevention of cardiovascular events and diabetes with angiotensin-receptor blockers in hypertension: LIFE, SCOPE, and VALUE.
Current hypertension reports 2005;7(3):155-7.
2005: Aud Høieggen; Ingrid Os; Sverre E Kjeldsen
[Uric acid--more deleterious than we thought?].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(10):1330-2.
2005: Peter S Sever; Neil R Poulter; Björn Dahlöf; Hans Wedel; Rory Collins; Gareth Beevers; Mark Caulfield; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA).
Diabetes care 2005;28(5):1151-7.
2005: Giovanni de Simone; Kristian Wachtell; Vittorio Palmieri; Darcy A Hille; Gareth Beevers; Björn Dahlöf; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Richard B Devereux
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.
Circulation 2005;111(15):1924-31.
2005: Frej Fyhrquist; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Darcy A Hille; Paulette A Lyle; Jonathan Edelman; Steven M Snapinn; Hans Wedel
Pulse pressure and effects of losartan or atenolol in patients with hypertension and left ventricular hypertrophy.
Hypertension 2005;45(4):580-5.
2005: Michael H Olsen; Eigil Fossum; Aud Høieggen; Kristian Wachtell; Elsa Hjerkinn; Shawna D Nesbitt; Ulrik B Andersen; Robert A Phillips; Cynthia L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Long-term treatment with losartan versus atenolol improves insulin sensitivity in hypertension: ICARUS, a LIFE substudy.
Journal of hypertension 2005;23(4):891-8.
2005: Michael H Olsen; Marina K Christensen; Kristian Wachtell; Christian Tuxen; Eigil Fossum; Lia E Bang; Niels Wiinberg; Richard B Devereux; Sverre E Kjeldsen; Per Hildebrandt; Harriet Dige-Petersen; Jens Rokkedal; Hans Ibsen
Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.
Journal of human hypertension 2005;19(4):301-7.
2005: Sverre E Kjeldsen; Paulette A Lyle; Jorge R Kizer; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Katherine E Harris; Hans Wedel
The effects of losartan compared to atenolol on stroke in patients with isolated systolic hypertension and left ventricular hypertrophy. The LIFE study.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(3):152-8.
2005: Kristian Wachtell; Mika Lehto; Eva Gerdts; Michael H Olsen; Björn Hornestam; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Richard B Devereux
Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):712-9.
2005: Kristian Wachtell; Björn Hornestam; Mika Lehto; David Slotwiner; Eva Gerdts; Michael H Olsen; Peter Aurup; Björn Dahlöf; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Lars H Lindholm; Markku S Nieminen; Jens Rokkedal; Richard B Devereux
Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study.
Journal of the American College of Cardiology 2005;45(5):705-11.
2005: Sverre E Kjeldsen
[Misinterpretation of research].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2005;125(3):327.
2005: Hans Ibsen; Michael H Olsen; Kristian Wachtell; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: losartan intervention for endpoint reduction in hypertension study.
Hypertension 2005;45(2):198-202.
2005: Sverre E Kjeldsen; Krzysztof Narkiewicz; Renata Cifková; Giuseppe Mancia
ESH statement on detection and punishment of abstract fraud and poster plagiarism.
Blood pressure 2005;14(6):322-3.
2005: Sverre E Kjeldsen; Krzysztof Narkiewicz; Thomas Hedner
ASCOT - more than a horse race!
Blood pressure 2005;14(5):262-3.
2005: Krzysztof Narkiewicz; Sverre E Kjeldsen; Thomas Hedner
Hypertension and coronary artery disease: mechanistic insights and therapeutic challenges.
Blood pressure 2005;14(5):260-1.
2005: Henrik M Reims; Knut Sevre; Eigil Fossum; Harald Mellem; Ivar Eide; Sverre E Kjeldsen
Adrenaline during mental stress in relation to fitness, metabolic risk factors and cardiovascular responses in young men.
Blood pressure 2005;14(4):217-26.
2005: Sverre E Kjeldsen; Thomas Hedner; Krzysztof Narkiewicz
Angiotensin receptor blockers and endpoint protection.
Blood pressure 2005;14(4):195.
2005: Henrik M Reims; Knut Sevre; Aud Høieggen; Eigil Fossum; Ivar Eide; Sverre E Kjeldsen
Blood viscosity: effects of mental stress and relations to autonomic nervous system function and insulin sensitivity.
Blood pressure 2005;14(3):159-69.
2005: Thomas Hedner; Sverre E Kjeldsen; Krzysztof Narkiewicz
Health economy of the metabolic syndrome pandemic.
Blood pressure 2005;14(3):131-2.
2005: Krzysztof Narkiewicz; Sverre E Kjeldsen; Thomas Hedner
Is smoking a causative factor of hypertension?
Blood pressure 2005;14(2):69-71.
2005: Gisli Jonsson; Michael Abdelnoor; Carl Müller; Sverre E Kjeldsen; Ingrid Os; Arne Westheim
A comparison of the two beta-blockers carvedilol and atenolol on left ventricular ejection fraction and clinical endpoints after myocardial infarction. a single-centre, randomized study of 232 patients.
Cardiology 2005;103(3):148-55.
2005: Sverre E Kjeldsen; Ingrid Os; Aud Høieggen; Kim Beckey; Gilbert W Gleim; Suzanne Oparil
Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2005;5(1):17-22.
2005: Jorge R Kizer; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Kristian Wachtell; Jonathan Edelman; Steven M Snapinn; Katherine E Harris; Richard B Devereux
Stroke reduction in hypertensive adults with cardiac hypertrophy randomized to losartan versus atenolol: the Losartan Intervention For Endpoint reduction in hypertension study.
Hypertension 2005;45(1):46-52.
2004: Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven M Snapinn; Katherine E Harris; Peter Aurup; Jonathan Edelman; Hans Wedel; Lars H Lindholm; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
JAMA : the journal of the American Medical Association 2004;292(19):2343-9.
2004: Sverre E Kjeldsen; Stevo Julius
Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
American heart journal 2004;148(5):747-54.
2004: Sverre E Kjeldsen
[Failing basis for the use of thiazides].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(20):2659-60.
2004: Henrik M Reims; Knut Sevre; Eigil Fossum; Aud Høieggen; Harald Mellem; Sverre E Kjeldsen
Relations between insulin sensitivity, fitness and autonomic cardiac regulation in healthy, young men.
Journal of hypertension 2004;22(10):2007-15.
2004: Hans Ibsen; Kristian Wachtell; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Ying Wan
Does albuminuria predict cardiovascular outcome on treatment with losartan versus atenolol in hypertension with left ventricular hypertrophy? A LIFE substudy.
Journal of hypertension 2004;22(9):1805-11.
2004: Henrik M Reims; Eigil Fossum; Aud Høieggen; andreas moan; Ivar Eide; Sverre E Kjeldsen
Adrenal medullary overactivity in lean, borderline hypertensive young men.
American journal of hypertension 2004;17(7):611-8.
2004: Arne Svilaas; Sverre E Kjeldsen; Kjell Midtbø; Arne Westheim; Jan Otto Syvertsen
[Prevention of myocardial infarction and stroke with statins].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(13-14):1821.
2004: Peter M Okin; Richard B Devereux; Markku S Nieminen; Sverker Jern; Lasse Oikarinen; Matti Viitasalo; Lauri Toivonen; Sverre E Kjeldsen; Stevo Julius; Steven M Snapinn; Björn Dahlöf
Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients.
Hypertension 2004;44(1):48-54.
2004: Michael A Weber; Stevo Julius; Sverre E Kjeldsen; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John H Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; M Anthony Schork; Beverly Smith; Alberto Zanchetti
Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial.
Lancet 2004;363(9426):2049-51.
2004: Stevo Julius; Sverre E Kjeldsen; Michael Weber; Hans R Brunner; Steffan Ekman; Lennart Hansson; Tsushung Hua; John H Laragh; Gordon T McInnes; Lada Mitchell; Francis Plat; Anthony M Schork; Beverly Smith; Alberto Zanchetti
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial.
Lancet 2004;363(9426):2022-31.
2004: Henrik M Reims; Sverre E Kjeldsen; W E Brady; Björn Dahlöf; Richard B Devereux; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Alcohol consumption and cardiovascular risk in hypertensives with left ventricular hypertrophy: the LIFE study.
Journal of human hypertension 2004;18(6):381-9.
2004: Eigil Fossum; Michael H Olsen; Aud Høieggen; Kristian Wachtell; Henrik M Reims; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen
Long-term plasma catecholamines in patients with hypertension and left ventricular hypertrophy treated with losartan or atenolol: ICARUS, a LIFE substudy.
Journal of human hypertension 2004;18(6):375-80.
2004: Peter M Okin; Richard B Devereux; Jennifer E Liu; Lasse Oikarinen; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Kristian Wachtell; Markku S Nieminen; Björn Dahlöf
Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study.
Journal of human hypertension 2004;18(6):403-9.
2004: Eva Gerdts; Per Omvik; Rune Mo; Sverre E Kjeldsen
[Hypertension and heart disease].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(6):802-5.
2004: Per Omvik; Bjørn Bratland; Gerhard Gerhardsen; Kjell Gisholt; Terje Risanger; Tore Smedsrud; Sverre E Kjeldsen
[Treatment of hypertension in patients with left ventricular hypertrophy].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(6):788-91.
2004: Stevo Julius; Michael H Alderman; Gareth Beevers; Björn Dahlöf; Richard B Devereux; Janice G Douglas; Jonathan Edelman; Katherine E Harris; Sverre E Kjeldsen; Shawna D Nesbitt; Otelio S Randall; Jackson T Wright
Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study.
Journal of the American College of Cardiology 2004;43(6):1047-55.
2004: Aud Høieggen; Michael H Alderman; Sverre E Kjeldsen; Stevo Julius; Richard B Devereux; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Cong Chen; Björn Dahlöf
The impact of serum uric acid on cardiovascular outcomes in the LIFE study.
Kidney international 2004;65(3):1041-9.
2004: Arne Svilaas; Sverre E Kjeldsen; Kjell Midtbø; Arne Westheim; Jan Otto Syvertsen
[Statin therapy for hypertensive patients].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2004;124(2):165-6.
2004: Henrik M Reims; Suzanne Oparil; Sverre E Kjeldsen; Richard B Devereux; Stevo Julius; William E Brady; Frej Fyhrquist; Hans Ibsen; Lars H Lindholm; Per Omvik; Hans Wedel; Gareth Beevers; Ulf de Faire; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Björn Dahlöf
Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the LIFE study.
Blood pressure 2004;13(6):376-84.
2004: Gordon T McInnes; Sverre E Kjeldsen
Never mind the quality, feel the width--ALLHAT revisited.
Blood pressure 2004;13(6):330-4.
2004: Sverre E Kjeldsen; Ingrid Os; Thomas Hedner; Anders Himmelmann
Renal hypertensive target organ damage--new evidence emerges in diabetics and smokers.
Blood pressure 2004;13(6):324-5.
2004: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Drugs 2004;64 Suppl 2():43-60.
2004: Thomas Hedner; Sverre E Kjeldsen; Anders Himmelmann
Valuable lessons from VALUE.
Blood pressure 2004;13(4):196-7.
2004: Henrik M Reims; Knut Sevre; Eigil Fossum; Aud Høieggen; Ivar Eide; Sverre E Kjeldsen
Plasma catecholamines, blood pressure responses and perceived stress during mental arithmetic stress in young men.
Blood pressure 2004;13(5):287-94.
2004: Eigil Fossum; Aud Høieggen; Henrik M Reims; andreas moan; Morten Rostrup; Ivar Eide; Sverre E Kjeldsen
High screening blood pressure is related to sympathetic nervous system activity and insulin resistance in healthy young men.
Blood pressure 2004;13(2):89-94.
2003: Kristian Wachtell; Hans Ibsen; Michael H Olsen; Knut Borch-Johnsen; Lars H Lindholm; Carl Erik Mogensen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Peter M Okin; Per Omvik; Suzanne Oparil; Hans Wedel; Steven M Snapinn; Peter Aurup
Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study.
Annals of internal medicine 2003;139(11):901-6.
2003: Sverre E Kjeldsen; Ingrid Os
Hypertension in very old people.
Journal of hypertension 2003;21(12):2249-50.
2003: Renata Cifkova; Serap Erdine; Robert Fagard; Csaba Farsang; Anthony M Heagerty; W Kiowski; Sverre E Kjeldsen; T Lüscher; J M Mallion; Giuseppe Mancia; Neil Poulter; K H Rahn; J L Rodicio; Luis M Ruilope; P van Zwieten; B Waeber; B Williams; Alberto Zanchetti
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.
Journal of hypertension 2003;21(10):1779-86.
2003: Sverre E Kjeldsen; Björn Dahlöf; Richard B Devereux; Lars H Lindholm; Markku S Nieminen; Suzanne Oparil; Hans Wedel
Comparison of the SCOPE and LIFE results.
Journal of hypertension 2003;21(9):1772-3; author reply 1773.
2003: Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Markku S Nieminen; Steven M Snapinn; Katherine E Harris; Peter Aurup; Jonathan Edelman; Bjorn Dahlof
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.
Circulation 2003;108(6):684-90.
2003: Richard B Devereux; Björn Dahlöf; Sverre E Kjeldsen; Stevo Julius; Peter Aurup; Gareth Beevers; Jonathan Edelman; Ulf de Faire; Frej Fyhrquist; Sigrid Helle Berg; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Hans Wedel
Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial.
Annals of internal medicine 2003;139(3):169-77.
2003: Stevo Julius; Sverre E Kjeldsen; Hans Brunner; Lennart Hansson; Francis Platt; Steffan Ekman; John H Laragh; Gordon T McInnes; Anthony M Schork; Beverly Smith; Michael Weber; Alberto Zanchetti
VALUE trial: Long-term blood pressure trends in 13,449 patients with hypertension and high cardiovascular risk.
American journal of hypertension 2003;16(7):544-8.
2003: Jørgen V Bjørnholt; Gunnar Erikssen; Sverre E Kjeldsen; Johan Bodegård; Erik Thaulow; Jan Erikssen
Fasting blood glucose is independently associated with resting and exercise blood pressures and development of elevated blood pressure.
Journal of hypertension 2003;21(7):1383-9.
2003: Thomas Hedner; Sverre E Kjeldsen; Anders Himmelmann
Novel aspects of therapeutics in Blood Pressure: drug therapy supplements.
Blood pressure. Supplement 2003;1():4.
2003: Michael H Olsen; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Jonathan Bella; Shawna D Nesbitt; Eigil Fossum; Sverre E Kjeldsen; Stevo Julius; Hans Ibsen
Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy.
Journal of human hypertension 2003;17(5):305-11.
2003: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Arni Kristinsson; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial.
Lancet 2003;361(9364):1149-58.
2003: Krister Kristianson; Frej Fyhrquist; Richard B Devereux; Sverre E Kjeldsen; Lars H Lindholm; Paulette A Lyle; Markku S Nieminen; Steven M Snapinn
An analysis of cholesterol control and statin use in the Losartan Intervention for Endpoint Reduction in Hypertension Study.
Clinical therapeutics 2003;25(4):1186-99.
2003: Hans Ibsen; Lars H Lindholm; Ole Lederballe Pedersen; Björn Dahlöf; Sverre E Kjeldsen
[The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with diabetes mellitus in the LIFE-study].
Ugeskrift for laeger 2003;165(5):459-62.
2003: Hans Ibsen; Ole Lederballe Pedersen; Björn Dahlöf; Sverre E Kjeldsen; Lars H Lindholm
[The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
Ugeskrift for laeger 2003;165(5):456-9.
2003: Sverre E Kjeldsen; Eigil Fossum; Henrik M Reims; Aud Høieggen
Hypertension treatment and stroke prevention.
Blood pressure 2003;12(5-6):264-8.
2003: Thomas Hedner; Anders Himmelmann; Sverre E Kjeldsen
Masked hypertension--a new entity and challenge for clinical hypertension research and management.
Blood pressure 2003;12(5-6):261-3.
2003: Anders Himmelmann; Sverre E Kjeldsen; Thomas Hedner
Recent hypertension guidelines: JNC-7 and 2003 ESH/ESC.
Blood pressure 2003;12(4):196-7.
2003: Henrik M Reims; Sverre E Kjeldsen; Giuseppe Mancia
Home blood pressure monitoring.
Blood pressure 2003;12(3):187-8.
2003: Sverre E Kjeldsen; Serap Erdine; Csaba Farsang; Peter Sleight; Guiseppe Mancia
1999 WHO/ISH Hypertension Guidelines--highlights & ESH Update.
Blood pressure 2003;12(3):181-2.
2003: Sverre E Kjeldsen; Thomas Hedner; Anders Himmelman
In light of ALLHAT and ASCOT: are there benefits of statins as add-on treatment in hypertensives?
Blood pressure 2003;12(3):132-3.
2003: Aud Höieggen; Eigil Fossum; Henrik M Reims; Sverre E Kjeldsen
Serum uric acid and hemorheology in borderline hypertensives and in subjects with established hypertension and left ventricular hypertrophy.
Blood pressure 2003;12(2):104-10.
2003: Thomas Hedner; Anders Himmelmann; Sverre E Kjeldsen
Contrasting messages but not contradicting results from ALLHAT and ANBP2.
Blood pressure 2003;12(2):68-9.
2002: Sverre E Kjeldsen; Björn Dahlöf; Richard B Devereux; Stevo Julius; Peter Aurup; Jonathan Edelman; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Steven M Snapinn; Hans Wedel
Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: a Losartan Intervention for Endpoint Reduction (LIFE) substudy.
JAMA : the journal of the American Medical Association 2002;288(12):1491-8.
2002: Lars H Lindholm; Hans Ibsen; Knut Borch-Johnsen; Michael H Olsen; Kristian Wachtell; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study.
Journal of hypertension 2002;20(9):1879-86.
2002: Sverre E Kjeldsen; Thomas Hedner; Jan Otto Syvertsen; Per Lund-Johansen; Lennart Hansson; Jan Lanke; Lars H Lindholm; Ulf de Faire; Björn Dahlöf; Bengt E Karlberg
Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.
Journal of hypertension 2002;20(6):1231-7.
2002: Lars H Lindholm; Hans Ibsen; Björn Dahlöf; Richard B Devereux; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Stevo Julius; Sverre E Kjeldsen; Krister Kristiansson; Ole Lederballe-Pedersen; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel; Peter Aurup; Jonathan Edelman; Steven M Snapinn
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):1004-10.
2002: Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.
Lancet 2002;359(9311):995-1003.
2002: Kristian Wachtell; Michael H Olsen; Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Markku S Nieminen; Peter M Okin; Vasilios Papademetriou; Carl E Mogensen; Knut Borch-Johnsen; Hans Ibsen
Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
Journal of hypertension 2002;20(3):405-12.
2002: Gisli Jonsson; Eigil Fossum; Sverre E Kjeldsen; Aud Høieggen; Ingrid Os; Ivar Eide; Arne Westheim
Lower plasma noradrenaline and blood viscosity on carvedilol vs atenolol in men with recent myocardial infarction.
Blood pressure 2002;11(6):377-84.
2002: Sverre E Kjeldsen; Thomas Hedner; Jan Otto Syvertsen; Per Lund-Johansen; Lennart Hansson
Comparison of home and office blood pressure in treated hypertensives in the Nordic Diltiazem (NORDIL) Study.
Blood pressure 2002;11(6):371-6.
2002: Johan Bodegard; Gunnar Erikssen; Leiv Sandvik; Sverre E Kjeldsen; Jørgen V Bjørnholt; Jan Erikssen
Early versus late morning measurement of blood pressure in healthy men. A potential source of measurement bias?
Blood pressure 2002;11(6):366-70.
2002: Sverre E Kjeldsen; Serap Erdine; Csaba Farsang; Peter Sleight; Guiseppe Mancia
1999 WHO/ISH Hypertension Guidelines--highlights & ESH update.
Journal of hypertension 2002;20(1):153-5.
2001: Per R Hildebrandt; Christian Tuxen; Sverre E Kjeldsen; P Lund-Johansen; L Hansson
[Are newer antihypertensive agents better than the older ones? Results of trials (CAPPP, STOP-2, NORDIL, INSIGHT and ALLHAT) with newer antihypertensive agents].
Ugeskrift for laeger 2001;164(1):18-21.
2001: Sverre E Kjeldsen; Csaba Farsang; P Sleigh; Guiseppe Mancia
1999 WHO/ISH hypertension guidelines--highlights and esh update.
Journal of hypertension 2001;19(12):2285-8.
2001: A E Ross; Arnljot Flaa; Aud Høieggen; Henrik M Reims; Ivar Eide; Sverre E Kjeldsen
Gender specific sympathetic and hemorrheological responses to mental stress in healthy young subjects.
Scandinavian cardiovascular journal : SCJ 2001;35(5):307-12.
2001: Henrik M Reims; Aud Høieggen; Eigil Fossum; Morten Rostrup; Ivar Eide; Sverre E Kjeldsen
Glucose disposal rates calculated from 60- to 90-minute isoglycemic hyperinsulinemic glucose clamp correlate with cardiovascular risk factors in borderline hypertensive young men.
Metabolism: clinical and experimental 2001;50(10):1175-80.
2001: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Anglo-Scandinavian Cardiac Outcomes Trial: a brief history, rationale and outline protocol.
Journal of human hypertension 2001;15 Suppl 1():S11-2.
2001: Sverre E Kjeldsen; R Mundal; Leiv Sandvik; Gunnar Erikssen; Erik Thaulow; Jan Erikssen
Supine and exercise systolic blood pressure predict cardiovascular death in middle-aged men.
Journal of hypertension 2001;19(8):1343-8.
2001: Peter M Okin; Richard B Devereux; Markku S Nieminen; Sverker Jern; Lasse Oikarinen; Matti Viitasalo; L Toivonen; Sverre E Kjeldsen; Stevo Julius; B Dahlöf
Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point.
Journal of the American College of Cardiology 2001;38(2):514-20.
2001: Aud Høieggen; Eigil Fossum; andreas moan; Morten Rostrup; Ivar Eide; Sverre E Kjeldsen
Biphasic effect of epinephrine on blood glucose during hyperinsulinemia in borderline hypertensive young men.
American journal of hypertension 2001;14(6 Pt 1):539-45.
2001: Alberto Zanchetti; Lennart Hansson; Björn Dahlöf; Dag Elmfeldt; Sverre E Kjeldsen; Rainer E Kolloch; P Larochelle; Gordon T McInnes; JM Mallion; Luis M Ruilope; Hans Wedel
Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group.
Journal of hypertension 2001;19(6):1149-59.
2001: Peter S Sever; Björn Dahlöf; Neil R Poulter; Hans Wedel; Gareth Beevers; Mark Caulfield; Rory Collins; Sverre E Kjeldsen; Gordon T McInnes; Jesper Mehlsen; Markku Nieminen; Eoin O'Brien; Jan Ostergren
Rationale, design, methods and baseline demography of participants of the Anglo-Scandinavian Cardiac Outcomes Trial. ASCOT investigators.
Journal of hypertension 2001;19(6):1139-47.
2001: Sverre E Kjeldsen; Jan Otto Syvertsen; Per Lund-Johansen; P Hildebrandt; Lennart Hansson
[Comparison of preventive effect of "new" and "old" antihypertensive agents].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 2001;121(11):1374-6.
2001: Henrik M Reims; Eigil Fossum; Sverre E Kjeldsen; Stevo Julius
Home blood pressure monitoring. Current knowledge and directions for future research.
Blood pressure 2001;10(5-6):271-87.
2001: Sverre E Kjeldsen; Stevo Julius; Thomas Hedner; Lennart Hansson
Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.
Blood pressure 2001;10(4):190-2.
2001: Eigil Fossum; K E Berge; Aud Høieggen; andreas moan; Morten Rostrup; Sverre E Kjeldsen; Ivar Eide; K Berg
Polymorphisms in candidate genes for blood pressure regulation in young men with normal or elevated screening blood pressure.
Blood pressure 2001;10(2):92-100.
2001: Sverre E Kjeldsen; Stevo Julius; H Brunner; Lennart Hansson; M Henis; S Ekman; John H Laragh; G McInnes; B Smith; M Weber; Alberto Zanchetti
Characteristics of 15,314 hypertensive patients at high coronary risk. The VALUE trial. The Valsartan Antihypertensive Long-term Use Evaluation.
Blood pressure 2001;10(2):83-91.
2000: Sverre E Kjeldsen; I Warnold; Lennart Hansson
Influence of gender on prevention of myocardial infarction by antihypertensives and acetylsalicylic acid: the HOT study.
The journal of gender-specific medicine : JGSM : the official journal of the Partnership for Women's Health at Columbia 2000;3(8):35-8.
2000: Peter M Okin; Richard B Devereux; Sverker Jern; Sverre E Kjeldsen; Stevo Julius; Björn Dahlöf
Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators.
Hypertension 2000;36(5):766-73.
2000: Sverre E Kjeldsen; Ingrid Os; Csaba Farsang; JM Mallion; Lennart Hansson; Peter Sleight
Treatment of hypertension in patients with type-2 diabetes mellitus.
Journal of hypertension 2000;18(9):1345-6.
2000: Sverre E Kjeldsen; Björn Dahlöf; R B Devereux; Stevo Julius; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint.
American journal of hypertension 2000;13(8):899-906.
2000: Lennart Hansson; Thomas Hedner; Per Lund-Johansen; Sverre E Kjeldsen; Lars H Lindholm; Jan Otto Syvertsen; Jan Lanke; Ulf de Faire; Björn Dahlöf; Bengt E Karlberg
Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.
Lancet 2000;356(9227):359-65.
2000: Sverre E Kjeldsen; Rainer E Kolloch; Gastone Leonetti; JM Mallion; Alberto Zanchetti; D Elmfeldt; Ingrid Warnold; Lennart Hansson
Influence of gender and age on preventing cardiovascular disease by antihypertensive treatment and acetylsalicylic acid. The HOT study. Hypertension Optimal Treatment.
Journal of hypertension 2000;18(5):629-42.
2000: Henrik M Reims; Aud Høieggen; Eigil Fossum; Sverre E Kjeldsen
Assessment of insulin sensitivity by 90 min isoglycaemic hyperinsulinaemic glucose clamp in healthy young men.
Blood pressure 2000;9(2-3):121-5.
2000: Aud Høieggen; Eigil Fossum; Shawna D Nesbitt; V Palmieri; Sverre E Kjeldsen
Blood viscosity, plasma adrenaline and fasting insulin in hypertensive patients with left ventricular hypertrophy. ICARUS, a LIFE Substudy. Insulin CARotids US Scandinavica.
Blood pressure 2000;9(2-3):83-90.
2000: Michael H Olsen; Eigil Fossum; Elsa Hjerkinn; Kristian Wachtell; Aud Høieggen; Shawna D Nesbitt; Ulrik B Andersen; R A Phillips; C L Gaboury; Hans Ibsen; Sverre E Kjeldsen; Stevo Julius
Relative influence of insulin resistance versus blood pressure on vascular changes in longstanding hypertension. ICARUS, a LIFE sub study. Insulin Carotids US Scandinavia.
Journal of hypertension 2000;18(1):75-81.
2000: Aud Høieggen; Eigil Fossum; andreas moan; Morten Rostrup; Ivar Eide; Sverre E Kjeldsen
Effects of hyperinsulinemia on sympathetic responses to mental stress.
American journal of hypertension 2000;13(1 Pt 1):21-8.
2000: Peter M Okin; Sverker Jern; Richard B Devereux; Sverre E Kjeldsen; Björn Dahlöf
Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
Hypertension 2000;35(1 Pt 1):13-8.
1999: Sverre E Kjeldsen; Kjell Midtbø; Ingrid Os; Arne Westheim
[An overview of hypertension studies with calcium antagonists].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1999;119(13):1878-82.
1999: Eigil Fossum; Aud Høieggen; andreas moan; Morten Rostrup; Sverre E Kjeldsen
Insulin sensitivity is related to physical fitness and exercise blood pressure to structural vascular properties in young men.
Hypertension 1999;33(3):781-6.
1999: Aud Høieggen; Eigil Fossum; andreas moan; Morten Rostrup; Ivar Eide; Sverre E Kjeldsen
Increased forearm blood flow during glucose clamp is related neither to insulin sensitivity nor to hyperinsulinemia in borderline hypertensive young men.
Blood pressure 1999;8(4):227-32.
1999: T O Klemsdal; andreas moan; Sverre E Kjeldsen
Effects of selective angiotensin II type 1 receptor blockade with losartan on arterial compliance in patients with mild essential hypertension.
Blood pressure 1999;8(4):214-9.
1998: Björn Dahlöf; Richard B Devereux; Stevo Julius; Sverre E Kjeldsen; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
Hypertension 1998;32(6):989-97.
1998: Aud Høieggen; Eigil Fossum; andreas moan; Ivar Eide; Sverre E Kjeldsen
Insulin modifies the glucose response to mental stress independently of forearm blood flow.
Blood pressure 1998;7(5-6):291-8.
1998: Eigil Fossum; Aud Høieggen; andreas moan; Morten Rostrup; G Nordby; Sverre E Kjeldsen
Relationship between insulin sensitivity and maximal forearm blood flow in young men.
Hypertension 1998;32(5):838-43.
1998: Ingebjørg Seljeflot; andreas moan; Trude Aspelin; T Tønnessen; Sverre E Kjeldsen; Harald Arnesen
Circulating levels of endothelin-1 during acute hyperinsulinemia in patients with essential hypertension treated with type 1 angiotensin receptor antagonist or placebo.
Metabolism: clinical and experimental 1998;47(3):292-6.
1998: Aud Høieggen; Eigil Fossum; andreas moan; E Enger; Sverre E Kjeldsen
Whole-blood viscosity and the insulin-resistance syndrome.
Journal of hypertension 1998;16(2):203-10.
1998: R Mundal; Sverre E Kjeldsen; Leiv Sandvik; Gunnar Erikssen; Erik Thaulow; Jan Erikssen
Clustering of coronary risk factors with increasing blood pressure at rest and during exercise.
Journal of hypertension 1998;16(1):19-22.
1997: R Mundal; Sverre E Kjeldsen; Leiv Sandvik; Gunnar Erikssen; Erik Thaulow; Jan Erikssen
Seasonal covariation in physical fitness and blood pressure at rest and during exercise in healthy middle-aged men.
Blood pressure 1997;6(5):269-73.
1997: Björn Dahlöf; R Devereux; Ulf de Faire; Frej Fyhrquist; Thomas Hedner; Hans Ibsen; Stevo Julius; Sverre E Kjeldsen; Krister Kristianson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
American journal of hypertension 1997;10(7 Pt 1):705-13.
1997: P von Brandis; Sverre E Kjeldsen; Knut Gjesdal
[Sudden cardiac death in hypertension].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1997;117(16):2337-40.
1997: Eigil Fossum; Aud Høieggen; andreas moan; G Nordby; T L Velund; Sverre E Kjeldsen
Whole blood viscosity, blood pressure and cardiovascular risk factors in healthy blood donors.
Blood pressure 1997;6(3):161-5.
1997: R Mundal; Sverre E Kjeldsen; Leiv Sandvik; Gunnar Erikssen; Erik Thaulow; Jan Erikssen
Predictors of 7-year changes in exercise blood pressure: effects of smoking, physical fitness and pulmonary function.
Journal of hypertension 1997;15(3):245-9.
1997: Eigil Fossum; Aud Høieggen; andreas moan; G Nordby; Sverre E Kjeldsen
Insulin sensitivity relates to other cardiovascular risk factors in young men: validation of some modifications of the hyperinsulinaemic, isoglycaemic glucose clamp technique.
Blood pressure. Supplement 1997;2():113-9.
1996: andreas moan; Aud Høieggen; Ingebjørg Seljeflot; T Risanger; H Arnesen; Sverre E Kjeldsen
The effect of angiotensin II receptor antagonism with losartan on glucose metabolism and insulin sensitivity.
Journal of hypertension 1996;14(9):1093-7.
1996: Sverre E Kjeldsen; J O Syvertsen; T Hedner
Cardiac conduction with diltiazem and beta-blockade combined. A review and report on cases.
Blood pressure 1996;5(5):260-3.
1996: R Mundal; Sverre E Kjeldsen; Leiv Sandvik; Gunnar Erikssen; Erik Thaulow; Jan Erikssen
Exercise blood pressure predicts mortality from myocardial infarction.
Hypertension 1996;27(3 Pt 1):324-9.
1996: andreas moan; Ivar Eide; Sverre E Kjeldsen
Metabolic and adrenergic characteristics of young men with insulin resistance.
Blood pressure. Supplement 1996;1():30-7.
1996: Sverre E Kjeldsen; andreas moan; J Petrin; Alan B Weder; Stevo Julius
Effects of increased arterial epinephrine on insulin, glucose and phosphate.
Blood pressure 1996;5(1):27-31.
1995: andreas moan; Aud Høieggen; G Nordby; Ivar Eide; Sverre E Kjeldsen
Effects of losartan on insulin sensitivity in severe hypertension: connections through sympathetic nervous system activity?
Journal of human hypertension 1995;9 Suppl 5():S45-50.
1995: andreas moan; Aud Høieggen; G Nordby; K Birkeland; Ivar Eide; Sverre E Kjeldsen
The glucose clamp procedure activates the sympathetic nervous system even in the absence of hyperinsulinemia.
The Journal of clinical endocrinology and metabolism 1995;80(11):3151-4.
1995: andreas moan; Aud Høieggen; G Nordby; Ingrid Os; Ivar Eide; Sverre E Kjeldsen
Mental stress increases glucose uptake during hyperinsulinemia: associations with sympathetic and cardiovascular responsiveness.
Metabolism: clinical and experimental 1995;44(10):1303-7.
1995: G Nordby; andreas moan; Sverre E Kjeldsen; Ivar Eide; Ingrid Os
Insulin resistance and sympathetic nervous system activity in hypertensive and normotensive premenopausal women.
Blood pressure 1995;4(5):287-92.
1995: S L Beckmann; Ingrid Os; Sverre E Kjeldsen; Ivar Eide; A S Westheim; I Hjermann
Effect of dietary counselling on blood pressure and arterial plasma catecholamines in primary hypertension.
American journal of hypertension 1995;8(7):704-11.
1995: Sverre E Kjeldsen; Alan B Weder; Brent M Egan; Richard Neubig; AJ Zweifler; Stevo Julius
Effect of circulating epinephrine on platelet function and hematocrit.
Hypertension 1995;25(5):1096-105.
1995: G Nordby; andreas moan; Sverre E Kjeldsen; Ingrid Os
Relationship between hemorheological factors and insulin sensitivity in normotensive and hypertensive premenopausal women.
American journal of hypertension 1995;8(5 Pt 1):439-44.
1995: andreas moan; G Nordby; Morten Rostrup; Ivar Eide; Sverre E Kjeldsen
Insulin sensitivity, sympathetic activity, and cardiovascular reactivity in young men.
American journal of hypertension 1995;8(3):268-75.
1994: R Mundal; Sverre E Kjeldsen; Leiv Sandvik; Gunnar Erikssen; Erik Thaulow; Jan Erikssen
Exercise blood pressure predicts cardiovascular mortality in middle-aged men.
Hypertension 1994;24(1):56-62.
1994: andreas moan; T Risanger; Ivar Eide; Sverre E Kjeldsen
The effect of angiotensin II receptor blockade on insulin sensitivity and sympathetic nervous system activity in primary hypertension.
Blood pressure 1994;3(3):185-8.
1994: Sverre E Kjeldsen; AJ Zweifler; J Petrin; Alan B Weder; Stevo Julius
Sympathetic nervous system involvement in essential hypertension: increased platelet noradrenaline coincides with decreased beta-adrenoreceptor responsiveness.
Blood pressure 1994;3(3):164-71.
1994: andreas moan; G Nordby; Ingrid Os; K I Birkeland; Sverre E Kjeldsen
Relationship between hemorrheologic factors and insulin sensitivity in healthy young men.
Metabolism: clinical and experimental 1994;43(4):423-7.
1993: Morten Rostrup; A Westheim; Sverre E Kjeldsen; Ivar Eide
Cardiovascular reactivity, coronary risk factors, and sympathetic activity in young men.
Hypertension 1993;22(6):891-9.
1993: Håvard H Mundal; G Nordby; K Lande; Knut Gjesdal; Sverre E Kjeldsen; Ingrid Os
Effect of cold pressor test and awareness of hypertension on platelet function in normotensive and hypertensive women.
Scandinavian journal of clinical and laboratory investigation 1993;53(6):585-91.
1993: Sverre E Kjeldsen; andreas moan; Morten Rostrup; G Nordby; Ingrid Os; Ivar Eide
[White coat hypertension and blood pressure measurement at home].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1993;113(15):1839-43.
1993: Sverre E Kjeldsen; J Petrin; Alan B Weder; Stevo Julius
Contrasting effects of epinephrine on forearm hemodynamics and arterial plasma norepinephrine.
American journal of hypertension 1993;6(5 Pt 1):369-75.
1993: Sverre E Kjeldsen; andreas moan; J Petrin; Alan B Weder; AJ Zweifler; Stevo Julius
Evaluation of self-measured home vs. clinic intra-arterial blood pressure.
Blood pressure 1993;2(1):28-34.
1993: Sverre E Kjeldsen; J O Syvertsen; P Lund-Johansen
[Can treatment of hypertension prevent myocardial infarction? New controlled clinical trials are proposed].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1993;113(6):737-40.
1993: Ingrid Os; Sverre E Kjeldsen; G Nordby; Ivar Eide; K Lande; I Hjermann; A Westheim
Sex differences in essential hypertension.
Journal of internal medicine 1993;233(1):13-9.
1992: G Nordby; Ingrid Os; Sverre E Kjeldsen; Ivar Eide
Mild essential hypertension in nonobese premenopausal women is characterized by low renin.
American journal of hypertension 1992;5(9):579-84.
1992: andreas moan; Sverre E Kjeldsen; G Nordby; Ingrid Os; I Eide; E Enger
[Treatment of hypertension in the elderly].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(17):2221-4.
1992: Sverre E Kjeldsen; R K Gupta; lisa krause; Alan B Weder; Stevo Julius
Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril.
American heart journal 1992;123(5):1433-8.
1992: andreas moan; Sverre E Kjeldsen; E Enger; H Ibsen; B Dahlöf; P Lund-Johansen
[Treatment of hypertension in Norway. Indications, therapeutic intensity and economic aspects].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1992;112(1):69-70.
1992: A Westheim; Ingrid Os; E Thaulow; Sverre E Kjeldsen; J Eritsland; Ivar Eide
Haemodynamic and neurohumoral effects of cold pressor test in severe heart failure.
Clinical physiology (Oxford, England) 1992;12(1):95-106.
1992: Sverre E Kjeldsen; Morten Rostrup; andreas moan; Håvard H Mundal; Knut Gjesdal; I K Eide
The sympathetic nervous system may modulate the metabolic cardiovascular syndrome in essential hypertension.
Journal of cardiovascular pharmacology 1992;20 Suppl 8():S32-9.
1991: Sverre E Kjeldsen; Morten Rostrup; Knut Gjesdal; Ivar Eide
The epinephrine-blood platelet connection with special reference to essential hypertension.
American heart journal 1991;122(1 Pt 2):330-6.
1991: Stevo Julius; lisa krause; N J Schork; A D Mejia; Kerin A Jones; Cosmas van de Ven; E H Johnson; M A Sekkarie; Sverre E Kjeldsen; J Petrin
Hyperkinetic borderline hypertension in Tecumseh, Michigan.
Journal of hypertension 1991;9(1):77-84.
1991: R K Gupta; Sverre E Kjeldsen; Evangeline D Motley-Johnson; Alan B Weder; AJ Zweifler; Stevo Julius
Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
Journal of cardiovascular pharmacology 1991;17(1):13-9.
1990: Stevo Julius; A Mejia; Kerin A Jones; lisa krause; N Schork; Cosmas van de Ven; E Johnson; J Petrin; M A Sekkarie; Sverre E Kjeldsen
"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.
Hypertension 1990;16(6):617-23.
1990: Eystein S Husebye; Sverre E Kjeldsen; K Lande; Knut Gjesdal; Ingrid Os; Ivar Eide
Increased arterial adrenaline is related to pain in uncomplicated myocardial infarction.
Journal of internal medicine 1990;228(6):617-22.
1990: A Westheim; Ingrid Os; Sverre E Kjeldsen; E Fønstelien; Ivar Eide
Renal haemodynamic and sympathetic responses to head-up tilt in essential hypertension.
Scandinavian journal of clinical and laboratory investigation 1990;50(8):815-22.
1990: Morten Rostrup; Sverre E Kjeldsen; Ivar Eide
Awareness of hypertension increases blood pressure and sympathetic responses to cold pressor test.
American journal of hypertension 1990;3(12 Pt 1):912-7.
1990: Oivind Ekeberg; Sverre E Kjeldsen; D T Greenwood; E Enger
Correlations between psychological and physiological responses to acute flight phobia stress.
Scandinavian journal of clinical and laboratory investigation 1990;50(6):671-7.
1990: R K Gupta; Sverre E Kjeldsen; lisa krause; J Kneisley; E Posvar; Alan B Weder; Stevo Julius
Hemodynamic effects of quinapril, a novel angiotensin-converting enzyme inhibitor.
Clinical pharmacology and therapeutics 1990;48(1):41-9.
1990: Sverre E Kjeldsen; Ole M Sejersted; P Frederichsen; P Leren; Ivar Eide
Increased erythrocyte magnesium in never treated essential hypertension.
American journal of hypertension 1990;3(7):573-5.
1990: Morten Rostrup; Håvard H Mundal; Sverre E Kjeldsen; Knut Gjesdal; Ivar Eide
Awareness of high blood pressure stimulates platelet release reaction.
Thrombosis and haemostasis 1990;63(3):367-70.
1990: Sverre E Kjeldsen; Ole M Sejersted; P Frederichsen; P Leren; Ivar Eide
Increased erythrocyte magnesium content in essential hypertension.
Scandinavian journal of clinical and laboratory investigation 1990;50(4):395-400.
1990: Oivind Ekeberg; Sverre E Kjeldsen; Ivar Eide; D T Greenwood; E Enger
Effects of beta 1- and beta 2-blockade on blood pressure and sympathetic responses to flight phobia stress.
Clinical pharmacology and therapeutics 1990;47(5):599-607.
1989: Sverre E Kjeldsen; Ole M Sejersted; P Frederichsen; P Leren; Ivar Eide
Increased erythrocyte magnesium in untreated essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S156-7.
1989: Sverre E Kjeldsen; Richard Neubig; Alan B Weder; AJ Zweifler
The hypertension-coronary heart disease dilemma: the catecholamine-blood platelet connection.
Journal of hypertension 1989;7(11):851-60.
1989: Sverre E Kjeldsen; N J Schork; P Leren; Ivar Eide
Arterial plasma norepinephrine correlates to blood pressure in middle-aged men with sustained essential hypertension.
American heart journal 1989;118(4):775-81.
1989: K Lande; Ingrid Os; Sverre E Kjeldsen; A Westheim; I Hjermann; Ivar Eide; Knut Gjesdal
Effect of dopamine and dopamine-antagonist infusion on blood platelet count, size and release reaction in hypertensive and normotensive subjects.
Scandinavian journal of clinical and laboratory investigation 1989;49(4):307-15.
1989: Oivind Ekeberg; B B Ellertsen; I Seeberg; Sverre E Kjeldsen
Plasma catecholamines in some airline passengers.
Scandinavian journal of clinical and laboratory investigation 1989;49(2):183-8.
1988: Sverre E Kjeldsen; Ingrid Os; A Westheim; K Lande; Knut Gjesdal; I Hjermann; Ivar Eide
Hyper-responsiveness to low-dose epinephrine infusion in mild essential hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1988;6(4):S581-3.
1988: Sverre E Kjeldsen; Knut Gjesdal; P Leren; Ivar Eide
Decreased platelet-free dopamine and unchanged noradrenaline and adrenaline in essential hypertension.
Thrombosis and haemostasis 1988;60(2):251-4.
1988: Sverre E Kjeldsen; Ingrid Os; A Westheim; P Frederichsen; I Hjermann; Ivar Eide; K Gautvik
Decreased serum phosphate in essential hypertension. Related to increased sympathetic tone.
American journal of hypertension 1988;1(4 Pt 1):403-9.
1988: S L Beckmann; Ingrid Os; Sverre E Kjeldsen; B Mogensen; K R Norum; I Hjermann
[Non-pharmacological treatment of mild to moderate hypertension. A randomized, controlled study--results 1 1/2 years later].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1988;108(22):1593-7.
1988: Sverre E Kjeldsen; A Westheim; K Lande; Knut Gjesdal; P Leren; E Enger; Ivar Eide
Sodium depletion increases platelet and plasma catecholamines in hypertensive men.
Hypertension 1988;11(5):477-82.
1988: K Lande; Sverre E Kjeldsen; Ingrid Os; A Westheim; I Hjermann; Ivar Eide; Knut Gjesdal
Increased platelet and vascular smooth muscle reactivity to low-dose adrenaline infusion in mild essential hypertension.
Journal of hypertension 1988;6(3):219-25.
1987: K Lande; Sverre E Kjeldsen; Ivar Eide; P Leren; Knut Gjesdal
Does increased platelet release normalize during anti-hypertensive treatment?
Thrombosis and haemostasis 1987;58(3):834-8.
1987: Y Myreng; K Lande; Sverre E Kjeldsen; Ivar Eide; H Grendahl; Knut Gjesdal
Increase in beta-thromboglobulin during exercise.
Thrombosis research 1987;48(1):111-5.
1987: K Lande; Ingrid Os; Sverre E Kjeldsen; A Westheim; I Hjermann; Ivar Eide; Knut Gjesdal
Increased platelet size and release reaction in essential hypertension.
Journal of hypertension 1987;5(4):401-6.
1987: Ingrid Os; Sverre E Kjeldsen; S L Beckmann; Ivar Eide; I Hjermann; P Leren; A Westheim
[Sodium restriction in hypertension. Sympathetic tonus, renin and vasopressin].
Tidsskrift for den Norske lægeforening : tidsskrift for praktisk medicin, ny række 1987;107(10-11):954-7.
1987: Ingrid Os; Sverre E Kjeldsen; A Westheim; I Aakesson; N Norman; E Enger; I Hjermann; Ivar Eide
Decreased central dopaminergic activity in essential hypertension.
Journal of hypertension 1987;5(2):191-7.
1987: Sverre E Kjeldsen; I Taylor; A Westheim; O P Foss; P Leren; Ivar Eide
Severe sodium restriction alone and with potassium supplementation does not alter blood lipoproteins in essential hypertension.
European journal of clinical investigation 1987;17(2):182-6.
1987: Ingrid Os; Sverre E Kjeldsen; A Westheim; I Akesson; Ivar Eide; J Skjøtø; I Hjermann; P Leren
Aging and urinary vasopressin excretion in healthy men.
Scandinavian journal of urology and nephrology 1987;21(3):235-9.
1987: Sverre E Kjeldsen; K Lande; Knut Gjesdal; A Westheim; O P Foss; P Leren; Ivar Eide
Increased platelet release reaction in 50-year-old men with essential hypertension: correlation with atherogenic cholesterol fractions.
American heart journal 1987;113(1):151-5.
1986: Sverre E Kjeldsen; K Lande; Knut Gjesdal; M B Jackson; A Westheim; P Frederichsen; P Leren; Ivar Eide
Increased plasma noradrenaline during severe sodium restriction does not stimulate platelet release in essential hypertension.
Thrombosis and haemostasis 1986;56(2):120-3.
1986: Sverre E Kjeldsen; A Westheim; I Aakesson; Ivar Eide; P Leren
Plasma adrenaline and noradrenaline during orthostasis in man: the importance of arterial sampling.
Scandinavian journal of clinical and laboratory investigation 1986;46(5):397-401.
1986: P Oian; K Lande; Sverre E Kjeldsen; Knut Gjesdal; I Aakesson; Ivar Eide; J M Maltau
Enhanced platelet release reaction related to arterial plasma adrenaline and blood pressure in pre-eclampsia.
British journal of obstetrics and gynaecology 1986;93(6):548-53.
1986: Ingrid Os; Sverre E Kjeldsen; J Skjøtø; A Westheim; K Lande; I Aakesson; P Frederichsen; P Leren; I Hjermann; Ivar Eide
Increased plasma vasopressin in low renin essential hypertension.
Hypertension 1986;8(6):506-13.
1986: Ingrid Os; Sverre E Kjeldsen; A Westheim; M B Jackson; I Aakesson; P Frederichsen; P Leren; Ivar Eide
Hormonal responses to treatment of high blood pressure with low-salt diet alone and combined with added potassium.
Acta medica Scandinavica. Supplementum 1986;714():93-7.
1986: Ingrid Os; Sverre E Kjeldsen; A Westheim; M B Jackson; I Akesson; P Frederichsen; Ivar Eide; P Leren
The effect of sodium depletion and potassium supplementation on vasopressin, renin and catecholamines in hypertensive men.
Acta medica Scandinavica 1986;220(3):195-203.
1986: Sverre E Kjeldsen; Ivar Eide; Ingrid Os; A Westheim; I Aakesson; S Børre Mogensen; P Frederichsen; I Hjermann; K Gautvik
Serum phosphate and sympathetic tone in mild essential hypertension.
Acta medica Scandinavica. Supplementum 1986;714():119-23.
1986: Ingrid Os; Sverre E Kjeldsen; A Westheim; N Normann; I Aakesson; I Hjermann; Ivar Eide
Central dopaminergic control of prolactin in essential hypertension.
Acta medica Scandinavica. Supplementum 1986;714():113-7.
1986: K Lande; Ingrid Os; Sverre E Kjeldsen; A Westheim; I Aakesson; I Hjermann; Ivar Eide; Knut Gjesdal
Platelet volume, platelet release reaction and platelet response to infused adrenaline are increased in essential hypertension.
Acta medica Scandinavica. Supplementum 1986;714():129-32.
1986: Knut Gjesdal; Sverre E Kjeldsen; K Lande; A Westheim; I Aakesson; O P Foss; P Leren; Ivar Eide
Blood platelet release correlates with serum lipids in 50 year old men with essential hypertension.
Acta medica Scandinavica. Supplementum 1986;714():125-8.
1985: Sverre E Kjeldsen; Ivar Eide; I Aakesson; P Oian; J M Maltau; K Lande; Knut Gjesdal
Increased arterial adrenaline is highly correlated to blood pressure and in vivo platelet function in pre-eclampsia.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1985;3(3):S93-5.
1985: Sverre E Kjeldsen; Ingrid Os; G Forsberg; I Aakesson; J Skjøtø; P Frederichsen; E Fønstelien; Ivar Eide
Dietary sodium intake increases vasopressin secretion in man.
Journal of clinical hypertension 1985;1(2):123-31.
1985: Ingrid Os; Sverre E Kjeldsen; I Aakesson; J Skjøtø; Ivar Eide; I Hjermann; P Leren
Evidence of age-related variation in plasma vasopressin of normotensive men.
Scandinavian journal of clinical and laboratory investigation 1985;45(3):263-8.
1984: Sverre E Kjeldsen; G Forsberg; Ivar Eide; I Aakesson; Ingrid Os; J Skjøtø; P Frederichsen
Dietary sodium intake and vasopressin excretion in man.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1984;2(3):S301-3.
1984: Ingrid Os; Sverre E Kjeldsen; I Aakesson; J Skjøtø; A Westheim; Ivar Eide; P Leren
Arteriovenous difference of plasma vasopressin in normal man and effect of posture.
Acta physiologica Scandinavica 1984;122(1):49-53.
1984: J Skjøtø; I Aakesson; Ingrid Os; Sverre E Kjeldsen; Ivar Eide; P Leren
Increased plasma vasopressin and serum uric acid in the low renin type of essential hypertension.
Acta medica Scandinavica 1984;215(2):165-72.
1983: Sverre E Kjeldsen; Ivar Eide; I Aakesson; P Leren
Increased arterial catecholamine concentrations in 50-year-old men with essential hypertension.
Scandinavian journal of clinical and laboratory investigation 1983;43(4):343-9.
1983: Sverre E Kjeldsen; Ivar Eide; I Aakesson; P Leren
Influence of body weight on plasma catecholamine patterns in middle-aged, normotensive men.
Scandinavian journal of clinical and laboratory investigation 1983;43(4):339-42.
1983: Sverre E Kjeldsen; Ivar Eide; I Aakesson; R Amundsen; I L Eriksen; P Leren
Increased plasma free dopamine after treatment with atenolol and oxprenolol in essential hypertension.
Acta medica Scandinavica 1983;214(5):367-71.
1983: Sverre E Kjeldsen; Knut Gjesdal; Ivar Eide; I Aakesson; R Amundsen; O P Foss; P Leren
Increased beta-thromboglobulin in essential hypertension: interactions between arterial plasma adrenaline, platelet function and blood lipids.
Acta medica Scandinavica 1983;213(5):369-73.